<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	 xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>SARMs &#8211; BEHEMOTH LABZ</title>
	<atom:link href="https://behemothlabz.com/category/sarms/feed/" rel="self" type="application/rss+xml" />
	<link>https://behemothlabz.com</link>
	<description>For all your Laboratory research needs</description>
	<lastBuildDate>Tue, 01 Sep 2026 09:53:16 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.2</generator>

<image>
	<url>https://behemothlabz.com/wp-content/uploads/2024/11/cropped-favi-1-01-32x32.png</url>
	<title>SARMs &#8211; BEHEMOTH LABZ</title>
	<link>https://behemothlabz.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>AC-262: Benefits, Side Effects, and Mechanism Explained</title>
		<link>https://behemothlabz.com/ac-262-benefits-side-effects-and-mechanism-explained/</link>
					<comments>https://behemothlabz.com/ac-262-benefits-side-effects-and-mechanism-explained/#respond</comments>
		
		<dc:creator><![CDATA[Team BehemothLabz]]></dc:creator>
		<pubDate>Tue, 24 Feb 2026 08:49:27 +0000</pubDate>
				<category><![CDATA[SARMs]]></category>
		<guid isPermaLink="false">https://behemothlabz.com/?p=140366</guid>

					<description><![CDATA[What is AC-262?  Researchers explore AC-262 as a promising SARM in preclinical lab settings. AC-262 draws attention for its potential in studies on muscle tissue, bone density, and androgen-related pathways. Researchers use it to investigate tissue-selective effects without the broad binding seen in traditional androgens in preclinical models. BehemothLabz supplies AC-262 in high-purity forms, ideal [...]]]></description>
										<content:encoded><![CDATA[<h2><b>What is AC-262? </b></h2>
<span style="font-weight: 400;">Researchers explore AC-262 as a promising SARM in preclinical lab settings. AC-262 draws attention for its potential in studies on muscle tissue, bone density, and androgen-related pathways. Researchers use it to investigate tissue-selective effects without the broad binding seen in traditional androgens in preclinical models. BehemothLabz supplies AC-262 in high-purity forms, ideal for controlled experiments on cellular mechanisms.</span>
<img loading="lazy" decoding="async" class="aligncenter wp-image-140369 " src="https://behemothlabz.com/wp-content/uploads/2026/02/AC-262-356-17mg-15ml-scaled-1-728x800.webp" alt="BEHEMOTH LABZ SARMs" width="262" height="288" srcset="https://behemothlabz.com/wp-content/uploads/2026/02/AC-262-356-17mg-15ml-scaled-1-728x800.webp 728w, https://behemothlabz.com/wp-content/uploads/2026/02/AC-262-356-17mg-15ml-scaled-1-364x400.webp 364w, https://behemothlabz.com/wp-content/uploads/2026/02/AC-262-356-17mg-15ml-scaled-1-768x845.webp 768w, https://behemothlabz.com/wp-content/uploads/2026/02/AC-262-356-17mg-15ml-scaled-1-1397x1536.webp 1397w, https://behemothlabz.com/wp-content/uploads/2026/02/AC-262-356-17mg-15ml-scaled-1-1862x2048.webp 1862w, https://behemothlabz.com/wp-content/uploads/2026/02/AC-262-356-17mg-15ml-scaled-1-510x561.webp 510w, https://behemothlabz.com/wp-content/uploads/2026/02/AC-262-356-17mg-15ml-scaled-1-64x70.webp 64w" sizes="auto, (max-width: 262px) 100vw, 262px" />
<p style="text-align: center;"><strong><a class="article-blog-btn" href="https://behemothlabz.com/product/ac-262356-liquid/">AC-262,356</a></strong></p>

<h2><b>Mechanism of Action</b></h2>
<span style="font-weight: 400;">AC-262 selectively binds to androgen receptors (AR). Research indicates that it stimulates AR in muscle and bone cells but does not affect the prostate and other tissues. This discriminatory nature is caused by its chemical structure. AC-262 is a non-steroidal quinolinone derivative. Scientists observe that it recruits co-activators to the AR differently than steroidal androgens do. It triggers gene transcription for muscle protein synthesis without overstimulating AR in reproductive tissues in cell cultures.</span>

<span style="font-weight: 400;">Key pathways include the PI3K/Akt/mTOR route. They are associated with skeletal muscle model hypertrophy. It enhances Akt phosphorylation and, hence, global protein synthesis in myoblast cultures.AC-262 also modulates MAPK/ERK signaling, which stimulates cell proliferation in bone osteoblasts. </span>

<span style="font-weight: 400;">It promotes the upregulation of follistatin and the downregulation of myostatin in animals. Experiments demonstrate greater AR nuclear translocation in muscle fibers, which results in increased expression of genes such as IGF-1 and myosin heavy chain.</span>

<span style="font-weight: 400;">Preclinical evidence shows that it activates PPAR</span><span style="font-weight: 400;">δ</span><span style="font-weight: 400;"> in fat cells. This activation shifts the energy use toward oxidation in muscle tissues. The mechanism has been observed in ovariectomized rat models, where it preserves lean mass under stress.</span>
<h2><b>Chemical Properties of AC-262</b></h2>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><b>Synonyms:</b><span style="font-weight: 400;">AC-262,536; 4-[(2S)-2-(3-chlorophenoxy)propylamino]-2-quinolinecarboxamide.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><b>Molecular Formula:</b><span style="font-weight: 400;"> C18H18ClN3.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><b>Molecular Weight</b><span style="font-weight: 400;">:  311.81 g/mol.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><b>PubChem CID:</b><span style="font-weight: 400;"> 9864875.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><b>Shelf Life:</b><span style="font-weight: 400;"> Stable for 24–36 months at -20°C in lyophilized form; avoid light and moisture.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><b>Solubility:</b><span style="font-weight: 400;"> Soluble in DMSO and ethanol; limited in water, aiding reconstitution protocols.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><b>Purity:</b><span style="font-weight: 400;"> Typically &gt;99% via HPLC from verified suppliers like BehemothLabz.</span></li>
</ul>
<h2><b>Potential Research Applications/Benefits of AC-262</b></h2>
<span style="font-weight: 400;">Preclinical data spotlight AC-262 across muscle, bone, and metabolic investigations and found these benefits:</span>
<h3><b>Muscle Hypertrophy</b></h3>
<span style="font-weight: 400;">AC-262 increases fiber cross-sectional area in rodent models of muscle atrophy. Researchers attribute this to upregulated AR-mediated protein synthesis. AC-262 also reverses glucocorticoid-induced atrophy in lab models. It restores IGF-1 signaling in dexamethasone-exposed myoblasts to avert FOXO3a upregulation and muscle breakdown.</span>
<h3><b>Bone Density Effects</b></h3>
<span style="font-weight: 400;">AC-262 maintains the volume of the trabecular bone in mice. Fracture healing models benefit, too. AC-262 accelerates callus formation in tibial defects. It serves as a tool for research on the mechanisms of osteoporosis.</span>
<h3><b>Metabolic and Lipid Effects</b></h3>
<span style="font-weight: 400;">AC-262 influences fat distribution in high-fat diet rodents. It reduces visceral fat pad weights while sparing subcutaneous depots. Glucose tests increase insulin sensitivity. It also increases the endurance metrics in mice. Mice performing on wheel-running indicate increased voluntary movement and fatigue resistance.</span>
<h3><b>Vascular and Cardiovascular Impacts</b></h3>
<span style="font-weight: 400;">Vascular smooth muscle cells treated with AC-262 proliferate less than with testosterone in preclinical research. It inhibits neointimal hyperplasia in balloon-injured rat carotids, reducing lesion area. This bias is helpful to atherosclerosis models. Studies of the heart tissue show that cardiac function was intact in pressure-overload hypertrophy mice.</span>
<h3><b>Neurological and Cognitive Angles</b></h3>
<span style="font-weight: 400;">Emerging data explore AC-262 in androgen-deprived brain models. It upregulates BDNF in hippocampal neurons. It supports synaptic spine density. Rodent maze tasks show spatial memory retention, which fuels the AR-neuroplasticity hypotheses.</span>
<h2><b>Side Effects in Preclinical Models</b></h2>
<span style="font-weight: 400;">Labs monitor AC-262 closely for dose-dependent effects as it shows a wide therapeutic window, but high doses reveal profiles in preclinical models.</span>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Minimal prostate weight increase</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Mild testosterone suppression</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Temporary libido decrease</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Transient fatigue</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Elevation of liver enzymes.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Mild increase in hematocrit</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Transient hypercalcemia</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Liver Injury</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Severe muscle damage</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Tendon rupture</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Behavioral changes</span></li>
</ul>
<h2><b>Why Choose BehemothLabz for AC-262?</b></h2>
<span style="font-weight: 400;">BehemothLabz is best at providing AC-262 for intensive research. They offer products with purity&gt;99% HPLC, tested by a third party to verify purity.</span>
<h3><b>Key advantages:</b></h3>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Fast international delivery</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Expert advice</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Verified payments</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Bulk options</span></li>
</ul>
<h2><b>Legal Status</b></h2>
<span style="font-weight: 400;">AC-262 qualifies as a research chemical. It is not FDA-approved for any clinical trials. Authorities restrict it to licensed lab use only.</span>

<b>Disclaimer:</b><span style="font-weight: 400;"> BehemothLabz products are intended for laboratory use only. Strictly for laboratory research use only, not as diagnostic, therapeutic, or human.</span>
<h2><b>FAQs</b></h2>
<h3><b>What are the benefits of AC-262 in the preclinical model?</b></h3>
<span style="font-weight: 400;">AC-262 increases muscle weight, and bone density is considered a marker of anabolic activity in castrated rat models.</span>
<h3><b>How does AC-262 work?</b></h3>
<span style="font-weight: 400;">AC-262 is a partial agonist at the androgen receptor; that is, it binds receptors in muscle and bone tissue to stimulate growth, but it has a much lower affinity for the prostate and seminal vesicles than testosterone does.</span>
<h3><b>Is AC-262 suppressive to testosterone in preclinical models?</b></h3>
<span style="font-weight: 400;">Yes, it is capable of suppressing the production of natural testosterone, as most SARMs do.</span>
<h3><b>Is AC-262 legal?</b></h3>
<span style="font-weight: 400;">AC-262 has not been approved by the FDA for use in human food and is considered a research chemical.</span>
<h2><b>References</b></h2>
<ol>
 	<li><span style="font-weight: 400;">     </span><span style="font-weight: 400;">Barrios, M.M., Deconinck, E., Vanhee, C., Lamme, E.K., ‘t Hart‐Bakker, I., Syversen, P.V., Bøyum, O., Li‐Ship, G., Young, S., Blazewicz, A. and Poplawska, M., 2025. SARMs, Metabolic Modulators and Growth Hormone Secretagogues in Suspected Illegal Medicines, Bought as Sport Performance Enhancers: A Retro‐and Prospective Study Within the GEON. </span><i><span style="font-weight: 400;">Drug Testing and Analysis</span></i><span style="font-weight: 400;">.</span></li>
 	<li><span style="font-weight: 400;">     </span><span style="font-weight: 400;">Wen, J., Syed, B., Leapart, J., Shehabat, M., Ansari, U., Akhtar, M., Razick, D. and Pai, D., 2025. Selective androgen receptor modulators (SARMs) effects on physical performance: a systematic review of randomized control trials. </span><i><span style="font-weight: 400;">Clinical endocrinology</span></i><span style="font-weight: 400;">, </span><i><span style="font-weight: 400;">102</span></i><span style="font-weight: 400;">(1), pp.3-27.</span></li>
 	<li><span style="font-weight: 400;">     </span><span style="font-weight: 400;">Borecki, R., Byczkiewicz, P. and Słowikowska-Hilczer, J., 2025. Selective androgen receptor modulators (SARMs)—potential anabolic drugs for the treatment of cachexia and frailty syndrome. </span><i><span style="font-weight: 400;">Endokrynologia Polska</span></i><span style="font-weight: 400;">.</span></li>
 	<li><b></b><span style="font-weight: 400;">     </span><span style="font-weight: 400;">Barsky, S.T. and Monks, D.A., 2025. The role of androgens and global and tissue-specific androgen receptor expression on body composition, exercise adaptation, and performance. </span><i><span style="font-weight: 400;">Biology of Sex Differences</span></i><span style="font-weight: 400;">, </span><i><span style="font-weight: 400;">16</span></i><span style="font-weight: 400;">(1), p.28.</span></li>
</ol>]]></content:encoded>
					
					<wfw:commentRss>https://behemothlabz.com/ac-262-benefits-side-effects-and-mechanism-explained/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Ligandrol versus RAD 140: Scientific Comparison</title>
		<link>https://behemothlabz.com/ligandrol-versus-rad-140-scientific-comparison/</link>
					<comments>https://behemothlabz.com/ligandrol-versus-rad-140-scientific-comparison/#respond</comments>
		
		<dc:creator><![CDATA[Team BehemothLabz]]></dc:creator>
		<pubDate>Tue, 24 Feb 2026 08:49:17 +0000</pubDate>
				<category><![CDATA[SARMs]]></category>
		<guid isPermaLink="false">https://behemothlabz.com/?p=140356</guid>

					<description><![CDATA[Researchers explore Ligandrol (LGD-4033) and RAD140 (Testolone) in preclinical models to assess their effects on muscle tissue, bone density, and androgen signaling pathways. This blog explores deep into both. Let's break them down side by side! What is Ligandrol? Buy LGD 4033 Ligandrol, also known as LGD-4033, is a non-steroidal SARM developed through lab synthesis. [...]]]></description>
										<content:encoded><![CDATA[<span style="font-weight: 400;">Researchers explore Ligandrol (LGD-4033) and RAD140 (Testolone) in preclinical models to assess their effects on muscle tissue, bone density, and androgen signaling pathways. This blog explores deep into both. Let's break them down side by side!</span>
<h2><b>What is Ligandrol?</b></h2>
<img loading="lazy" decoding="async" class="aligncenter wp-image-126598" src="https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1.webp" alt="LGD 4033" width="328" height="328" srcset="https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1.webp 800w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-400x400.webp 400w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-280x280.webp 280w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-768x768.webp 768w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-39x39.webp 39w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-18x18.webp 18w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-25x25.webp 25w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-510x510.webp 510w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-100x100.webp 100w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-64x64.webp 64w" sizes="auto, (max-width: 328px) 100vw, 328px" />
<p style="text-align: center;"><strong><a class="article-blog-btn" href="https://behemothlabz.com/product/lgd-4033-ligandrol-capsules/">Buy LGD 4033</a></strong></p>
<a href="https://behemothlabz.com/product/lgd-4033-ligandrol-liquid/"><span style="font-weight: 400;">Ligandrol</span></a><span style="font-weight: 400;">, also known as LGD-4033, is a non-steroidal SARM developed through lab synthesis. Developers designed it to target androgen receptors selectively in preclinical models. It has the potential to bind those receptors in muscle and bone tissues in preclinical models.</span>

<span style="font-weight: 400;">Androgen receptors act like switches in cells. Once activated, they affect pathways associated with muscle growth and bone strength. The structure of Ligandrol is similar to testosterone. It is, however, focused on targeting tissue-specific action while sparing other tissues, such as the prostate, in laboratory tests. </span>

<span style="font-weight: 400;">In rodent models, Ligandrol increases anabolic signaling, thereby increasing protein synthesis in muscle fibers. It is one of the most important processes that is observed in the laboratory. Its ability to maintain lean mass is also observed in simulated atrophy conditions in preclinical models.</span>
<h2><b>What is RAD 140?</b></h2>
<img loading="lazy" decoding="async" class="aligncenter wp-image-128811" src="https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh.webp" alt="RAD 140 capsules &amp; liquid" width="350" height="350" srcset="https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh.webp 800w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-400x400.webp 400w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-280x280.webp 280w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-768x768.webp 768w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-39x39.webp 39w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-18x18.webp 18w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-25x25.webp 25w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-510x510.webp 510w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-100x100.webp 100w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-64x64.webp 64w" sizes="auto, (max-width: 350px) 100vw, 350px" />
<p style="text-align: center;"><strong><a class="article-blog-btn" href="/product/rad-140-testolone-capsules/">Buy RAD-140</a></strong></p>
<a href="https://behemothlabz.com/product/rad-140-testolone-liquid/"><span style="font-weight: 400;">RAD 140</span></a><span style="font-weight: 400;">, or Testolone, is also part of the SARM family. It has a high affinity for androgen receptors, and preclinical experiments have shown its muscle- and neural-tissue selectivity. This SARM has a distinct chemical backbone, which improves its selectivity. It activates receptors to induce anabolic effects with low off-target activity in experimental models. </span>

<span style="font-weight: 400;">RAD 140 has been repeatedly used in neuroprotection and muscle studies. RAD 140 in rodent models changes muscle repair and bone remodeling-related gene expression. The compound's design exhibits stronger receptor affinity than some peers, making it a preferred target in potency-focused research.</span>
<h2><b>How Do They Work?</b></h2>
<span style="font-weight: 400;">Both SARMs interact with androgen receptors. Nevertheless, their mechanisms differ slightly.</span>
<h3><b>Ligandrol</b></h3>
<span style="font-weight: 400;">Ligandrol enters cells, binds to androgen receptors in muscle and bone, triggering a cascade. The receptor complex translocates to the nucleus, where it interacts with DNA and triggers genes that promote muscle protein synthesis, initiating hypertrophy in preclinical models. </span>

<span style="font-weight: 400;">Ligandrol reinstates bone mineral density by increasing osteoblast activity in ovariectomized rat studies. It also reduces muscle wasting by upregulating IGF-1 signaling. Such effects stay tissue-specific, with low impact on reproductive organs in preclinical models.</span>
<h3><b>RAD 140</b></h3>
<span style="font-weight: 400;">It binds androgen receptors with high affinity, especially in skeletal muscle and brain tissues. RAD 140 recruits coactivators to amplify transcription of anabolic proteins, such as myosin heavy chain. Castrated male rats show that levator ani muscle weight is elevated in a dose-dependent manner.</span>

<span style="font-weight: 400;">Research in the neuronal cell lines suggests it crosses the blood-brain barrier. RAD 140 also regulates neuroprotective genes, potentially shielding against oxidative stress in brain models. This is a dual muscle-neuro action that differentiates it in multifaceted research in preclinical uses.</span>
<h2><b>Similarities between Ligandrol and RAD 140</b></h2>
<span style="font-weight: 400;">Preclinical research has identified the following shared characteristics of Ligandrol and RAD 140.</span>
<table>
<tbody>
<tr>
<td><b>Similar Features</b></td>
<td><b>Ligandrol and RAD 140</b></td>
</tr>
<tr>
<td><b>Non-Steroidal SARMs</b></td>
<td><span style="font-weight: 400;">Both compounds are non-steroidal SARMs and feature small molecule structures that selectively target androgen receptors. These features reduce unwanted activation in non-muscle tissues during preclinical studies.</span></td>
</tr>
<tr>
<td><b>Tissue Selectivity</b></td>
<td><span style="font-weight: 400;">These compounds show tissue selectivity as neither heavily impacts the seminal vesicles or prostate in rodent models.</span></td>
</tr>
<tr>
<td><b>Androgen Response</b></td>
<td><span style="font-weight: 400;">Both SARMs influence androgen-responsive genes</span></td>
</tr>
<tr>
<td><b>Dose-Dependent Effects</b></td>
<td><span style="font-weight: 400;">These compounds show dose-dependent effects as low doses yield mild anabolic shifts. Higher doses amplify muscle fiber without causing toxicity.</span></td>
</tr>
</tbody>
</table>
<h2><b>Differences between Ligandrol and RAD 140</b></h2>
<span style="font-weight: 400;">While similarities exist, distinct profiles also emerge.</span>
<table>
<tbody>
<tr>
<td><b>Distinctive Features</b></td>
<td><b>Ligandrol</b></td>
<td><b>RAD 140</b></td>
</tr>
<tr>
<td><b>Chemical Structure</b></td>
<td><span style="font-weight: 400;">It has a benzimidazole core for balanced binding.</span></td>
<td><span style="font-weight: 400;">It has a dihydroquinolinone scaffold with higher potency.</span></td>
</tr>
<tr>
<td><b>Targeted Tissue</b></td>
<td><span style="font-weight: 400;">Ligandrol excels in muscle and bone research.</span></td>
<td><span style="font-weight: 400;">RAD 140 can extend to neural tissues.</span></td>
</tr>
<tr>
<td><b>Half-Life</b></td>
<td><span style="font-weight: 400;">24 to 36 hours.</span></td>
<td><span style="font-weight: 400;">It lasts around 60 hours.</span></td>
</tr>
<tr>
<td><b>Neuroprotective Potential</b></td>
<td><span style="font-weight: 400;">It lacks neural data as it focuses purely on musculoskeletal endpoints.</span></td>
<td><span style="font-weight: 400;">RAD 140 stands out here. Traumatic brain injury models in mice reveal reduced lesion volume.</span></td>
</tr>
<tr>
<td><b>Side Effect Profile</b></td>
<td><span style="font-weight: 400;">It may cause elevations in liver enzymes in rats at high doses.</span></td>
<td><span style="font-weight: 400;">It causes less hepatotoxicity. It can lead to pronounced suppression of natural testosterone in animal models.</span></td>
</tr>
</tbody>
</table>
<h2><b>Side Effects in Laboratory Studies</b></h2>
<span style="font-weight: 400;">Preclinical research indicates the following dose-dependent side effects of these two SARMs:</span>
<h3><b>Ligandrol</b></h3>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Transient ALT/AST elevation</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Mild HDL drop</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Site irritations</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Altered hormone signaling</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Behavioral shifts</span></li>
</ul>
<h3><b>RAD 140</b></h3>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Potential for aggression in behavioral assays</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Stronger lipid shifts</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Seizure-like activity at extremes</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Site reactions</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Changes in sleep patterns</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Flushing responses</span></li>
</ul>
<h2><b>Legal Status</b></h2>
<span style="font-weight: 400;">Neither Ligandrol nor RAD 140 is FDA-approved. Labs restrict them to authorized research only. Researchers procure them from compliant sources, such as </span><a href="https://behemothlabz.com/#"><span style="font-weight: 400;">BehemothLabz</span></a><span style="font-weight: 400;">, for preclinical experiments. Always verify local regulations.</span> <span style="font-weight: 400;">Human use remains prohibited worldwide.</span>
<h2><b>Final Thoughts</b></h2>
<span style="font-weight: 400;">Ligandrol and RAD140 are potent tools in SARM research. Ligandrol provides consistent muscle- and bone-focused effects at a balanced potency, whereas RAD 140 may have neural effects and high selectivity. Their anabolic targeting similarities contrast with their differences in structure, duration, and application, which adds to laboratory comparisons. For your next experiment, BehemothLabz provides high-purity options.</span>
<h2><b>FAQs</b></h2>
<h3><b>Is LGD-4033 testosterone-stimulating in preclinical models?</b></h3>
<span style="font-weight: 400;">LGD-4033 is also associated with dose-dependent suppression of total testosterone in preclinical models.</span>
<h3><b>How can Ligandrol and RAD 140 be used in a preclinical model?</b></h3>
<span style="font-weight: 400;">Ligandrol and RAD 140 can stimulate bone and muscle development in the preclinical research models.</span>
<h3><b>What are the benefits of RAD 140 in laboratory experiments?</b></h3>
<span style="font-weight: 400;">RAD 140 may preserve bone mineral density and lean mass in preclinical aging male mice models.</span>]]></content:encoded>
					
					<wfw:commentRss>https://behemothlabz.com/ligandrol-versus-rad-140-scientific-comparison/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Ligandrol Vs RAD 140: Scientific Comparison</title>
		<link>https://behemothlabz.com/ligandrol-vs-rad-140/</link>
					<comments>https://behemothlabz.com/ligandrol-vs-rad-140/#respond</comments>
		
		<dc:creator><![CDATA[Team BehemothLabz]]></dc:creator>
		<pubDate>Tue, 10 Feb 2026 08:37:09 +0000</pubDate>
				<category><![CDATA[SARMs]]></category>
		<guid isPermaLink="false">https://behemothlabz.com/?p=139446</guid>

					<description><![CDATA[Researchers explore Ligandrol (LGD-4033) and RAD140 (Testolone) in preclinical models to assess their effects on muscle tissue, bone density, and androgen signaling pathways. This blog explores deep into both. Let's break them down side by side! What is Ligandrol? Buy LGD 4033 Ligandrol, also known as LGD-4033, is a non-steroidal SARM developed through lab synthesis. [...]]]></description>
										<content:encoded><![CDATA[<span style="font-weight: 400;">Researchers explore Ligandrol (LGD-4033) and RAD140 (Testolone) in preclinical models to assess their effects on muscle tissue, bone density, and androgen signaling pathways. This blog explores deep into both. Let's break them down side by side!</span>
<h2><b>What is Ligandrol?</b></h2>
<img loading="lazy" decoding="async" class="aligncenter wp-image-126598" src="https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1.webp" alt="LGD 4033" width="328" height="328" srcset="https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1.webp 800w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-400x400.webp 400w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-280x280.webp 280w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-768x768.webp 768w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-39x39.webp 39w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-18x18.webp 18w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-25x25.webp 25w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-510x510.webp 510w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-100x100.webp 100w, https://behemothlabz.com/wp-content/uploads/2025/08/lgd-main-1-64x64.webp 64w" sizes="auto, (max-width: 328px) 100vw, 328px" />
<p style="text-align: center;"><strong><a class="article-blog-btn" href="https://behemothlabz.com/product/lgd-4033-ligandrol-capsules/">Buy LGD 4033</a></strong></p>
<a href="https://behemothlabz.com/product/lgd-4033-ligandrol-liquid/"><span style="font-weight: 400;">Ligandrol</span></a><span style="font-weight: 400;">, also known as LGD-4033, is a non-steroidal SARM developed through lab synthesis. Developers designed it to target androgen receptors selectively in preclinical models. It has the potential to bind those receptors in muscle and bone tissues in preclinical models.</span>

<span style="font-weight: 400;">Androgen receptors act like switches in cells. Once activated, they affect pathways associated with muscle growth and bone strength. The structure of Ligandrol is similar to testosterone. It is, however, focused on targeting tissue-specific action while sparing other tissues, such as the prostate, in laboratory tests. </span>

<span style="font-weight: 400;">In rodent models, Ligandrol increases anabolic signaling, thereby increasing protein synthesis in muscle fibers. It is one of the most important processes that is observed in the laboratory. Its ability to maintain lean mass is also observed in simulated atrophy conditions in preclinical models.</span>
<h2><b>What is RAD 140?</b></h2>
<img loading="lazy" decoding="async" class="aligncenter wp-image-128811" src="https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh.webp" alt="RAD 140" width="282" height="282" srcset="https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh.webp 800w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-400x400.webp 400w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-280x280.webp 280w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-768x768.webp 768w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-39x39.webp 39w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-18x18.webp 18w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-25x25.webp 25w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-510x510.webp 510w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-100x100.webp 100w, https://behemothlabz.com/wp-content/uploads/2025/09/rad-140-bh-64x64.webp 64w" sizes="auto, (max-width: 282px) 100vw, 282px" />
<p style="text-align: center;"><strong><a class="article-blog-btn" href="/product/rad-140-testolone-capsules/">Buy RAD-140</a></strong></p>
<a href="https://behemothlabz.com/product/rad-140-testolone-liquid/"><span style="font-weight: 400;">RAD 140</span></a><span style="font-weight: 400;">, or Testolone, is also part of the SARM family. It has a high affinity for androgen receptors, and preclinical experiments have shown its muscle- and neural-tissue selectivity. This SARM has a distinct chemical backbone, which improves its selectivity. It activates receptors to induce anabolic effects with low off-target activity in experimental models. </span>

<span style="font-weight: 400;">RAD 140 has been repeatedly used in neuroprotection and muscle studies. RAD 140 in rodent models changes muscle repair and bone remodeling-related gene expression. The compound's design exhibits stronger receptor affinity than some peers, making it a preferred target in potency-focused research.</span>
<h2><b>How Do They Work?</b></h2>
<span style="font-weight: 400;">Both SARMs interact with androgen receptors. Nevertheless, their mechanisms differ slightly.</span>
<h3><b>Ligandrol</b></h3>
<span style="font-weight: 400;">Ligandrol enters cells, binds to androgen receptors in muscle and bone, triggering a cascade. The receptor complex translocates to the nucleus, where it interacts with DNA and triggers genes that promote muscle protein synthesis, initiating hypertrophy in preclinical models. </span>

<span style="font-weight: 400;">Ligandrol reinstates bone mineral density by increasing osteoblast activity in ovariectomized rat studies. It also reduces muscle wasting by upregulating IGF-1 signaling. Such effects stay tissue-specific, with low impact on reproductive organs in preclinical models.</span>
<h3><b>RAD 140</b></h3>
<span style="font-weight: 400;">It binds androgen receptors with high affinity, especially in skeletal muscle and brain tissues. RAD 140 recruits coactivators to amplify transcription of anabolic proteins, such as myosin heavy chain. Castrated male rats show that levator ani muscle weight is elevated in a dose-dependent manner.</span>

<span style="font-weight: 400;">Research in the neuronal cell lines suggests it crosses the blood-brain barrier. RAD 140 also regulates neuroprotective genes, potentially shielding against oxidative stress in brain models. This is a dual muscle-neuro action that differentiates it in multifaceted research in preclinical uses.</span>
<h2><b>Similarities between Ligandrol and RAD 140</b></h2>
<span style="font-weight: 400;">Preclinical research has identified the following shared characteristics of Ligandrol and RAD 140.</span>
<table>
<tbody>
<tr>
<td><b>Similar Features</b></td>
<td><b>Ligandrol and RAD 140</b></td>
</tr>
<tr>
<td><b>Non-Steroidal SARMs</b></td>
<td><span style="font-weight: 400;">Both compounds are non-steroidal SARMs and feature small molecule structures that selectively target androgen receptors. These features reduce unwanted activation in non-muscle tissues during preclinical studies.</span></td>
</tr>
<tr>
<td><b>Tissue Selectivity</b></td>
<td><span style="font-weight: 400;">These compounds show tissue selectivity as neither heavily impacts the seminal vesicles or prostate in rodent models.</span></td>
</tr>
<tr>
<td><b>Androgen Response</b></td>
<td><span style="font-weight: 400;">Both SARMs influence androgen-responsive genes</span></td>
</tr>
<tr>
<td><b>Dose-Dependent Effects</b></td>
<td><span style="font-weight: 400;">These compounds show dose-dependent effects as low doses yield mild anabolic shifts. Higher doses amplify muscle fiber without causing toxicity.</span></td>
</tr>
</tbody>
</table>
<h2><b>Differences between Ligandrol and RAD 140</b></h2>
<span style="font-weight: 400;">While similarities exist, distinct profiles also emerge.</span>
<table>
<tbody>
<tr>
<td><b>Distinctive Features</b></td>
<td><b>Ligandrol</b></td>
<td><b>RAD 140</b></td>
</tr>
<tr>
<td><b>Chemical Structure</b></td>
<td><span style="font-weight: 400;">It has a benzimidazole core for balanced binding.</span></td>
<td><span style="font-weight: 400;">It has a dihydroquinolinone scaffold with higher potency.</span></td>
</tr>
<tr>
<td><b>Targeted Tissue</b></td>
<td><span style="font-weight: 400;">Ligandrol excels in muscle and bone research.</span></td>
<td><span style="font-weight: 400;">RAD 140 can extend to neural tissues.</span></td>
</tr>
<tr>
<td><b>Half-Life</b></td>
<td><span style="font-weight: 400;">24 to 36 hours.</span></td>
<td><span style="font-weight: 400;">It lasts around 60 hours.</span></td>
</tr>
<tr>
<td><b>Neuroprotective Potential</b></td>
<td><span style="font-weight: 400;">It lacks neural data as it focuses purely on musculoskeletal endpoints.</span></td>
<td><span style="font-weight: 400;">RAD 140 stands out here. Traumatic brain injury models in mice reveal reduced lesion volume.</span></td>
</tr>
<tr>
<td><b>Side Effect Profile</b></td>
<td><span style="font-weight: 400;">It may cause elevations in liver enzymes in rats at high doses.</span></td>
<td><span style="font-weight: 400;">It causes less hepatotoxicity. It can lead to pronounced suppression of natural testosterone in animal models.</span></td>
</tr>
</tbody>
</table>
<h2><b>Side Effects in Laboratory Studies</b></h2>
<span style="font-weight: 400;">Preclinical research indicates the following dose-dependent side effects of these two SARMs:</span>
<h3><b>Ligandrol</b></h3>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Transient ALT/AST elevation</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Mild HDL drop</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Site irritations</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Altered hormone signaling</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Behavioral shifts</span></li>
</ul>
<h3><b>RAD 140</b></h3>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Potential for aggression in behavioral assays</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Stronger lipid shifts</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Seizure-like activity at extremes</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Site reactions</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Changes in sleep patterns</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Flushing responses</span></li>
</ul>
<h2><b>Legal Status</b></h2>
<span style="font-weight: 400;">Neither Ligandrol nor RAD 140 is FDA-approved. Labs restrict them to authorized research only. Researchers procure them from compliant sources, such as </span><a href="https://behemothlabz.com/#"><span style="font-weight: 400;">BehemothLabz</span></a><span style="font-weight: 400;">, for preclinical experiments. Always verify local regulations.</span> <span style="font-weight: 400;">Human use remains prohibited worldwide.</span>
<h2><b>Final Thoughts</b></h2>
<span style="font-weight: 400;">Ligandrol and RAD140 are potent tools in SARM research. Ligandrol provides consistent muscle- and bone-focused effects at a balanced potency, whereas RAD 140 may have neural effects and high selectivity. Their anabolic targeting similarities contrast with their differences in structure, duration, and application, which adds to laboratory comparisons. For your next experiment, BehemothLabz provides high-purity options.</span>
<h2><b>FAQs</b></h2>
<h3><b>Is LGD-4033 testosterone-stimulating in preclinical models?</b></h3>
<span style="font-weight: 400;">LGD-4033 is also associated with dose-dependent suppression of total testosterone in preclinical models.</span>
<h3><b>How can Ligandrol and RAD 140 be used in a preclinical model?</b></h3>
<span style="font-weight: 400;">Ligandrol and RAD 140 can stimulate bone and muscle development in the preclinical research models.</span>
<h3><b>What are the benefits of RAD 140 in laboratory experiments?</b></h3>
<span style="font-weight: 400;">RAD 140 may preserve bone mineral density and lean mass in preclinical aging male mice models.</span>]]></content:encoded>
					
					<wfw:commentRss>https://behemothlabz.com/ligandrol-vs-rad-140/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>MK 677 VS Testosterone Scientific Comparison</title>
		<link>https://behemothlabz.com/mk-677-vs-testosterone-comparison/</link>
					<comments>https://behemothlabz.com/mk-677-vs-testosterone-comparison/#respond</comments>
		
		<dc:creator><![CDATA[Team BehemothLabz]]></dc:creator>
		<pubDate>Wed, 28 Jan 2026 11:49:08 +0000</pubDate>
				<category><![CDATA[SARMs]]></category>
		<category><![CDATA[sarms]]></category>
		<guid isPermaLink="false">https://behemothlabz.com/?p=138571</guid>

					<description><![CDATA[Several compounds have shown promise for influencing muscle growth, strength, and overall performance in preclinical models. Two options, including MK-677 (Ibutamoren) and Testosterone, are currently under active research in the laboratory. In this blog, we are going to immerse ourselves in these compounds so we can understand their effects in the research experiments. What is [...]]]></description>
										<content:encoded><![CDATA[<p><span style="font-weight: 400;">Several compounds have shown promise for influencing muscle growth, strength, and overall performance in preclinical models. Two options, including MK-677 (Ibutamoren) and Testosterone, are currently under active research in the laboratory. In this blog, we are going to immerse ourselves in these compounds so we can understand their effects in the research experiments.</span></p>
<h2><b>What is </b><b>MK-677</b><b>?</b></h2>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-122687" src="https://behemothlabz.com/wp-content/uploads/2025/06/MK-677-a.webp" alt="MK677" width="344" height="344" srcset="https://behemothlabz.com/wp-content/uploads/2025/06/MK-677-a.webp 800w, https://behemothlabz.com/wp-content/uploads/2025/06/MK-677-a-400x400.webp 400w, https://behemothlabz.com/wp-content/uploads/2025/06/MK-677-a-280x280.webp 280w, https://behemothlabz.com/wp-content/uploads/2025/06/MK-677-a-768x768.webp 768w, https://behemothlabz.com/wp-content/uploads/2025/06/MK-677-a-39x39.webp 39w, https://behemothlabz.com/wp-content/uploads/2025/06/MK-677-a-18x18.webp 18w, https://behemothlabz.com/wp-content/uploads/2025/06/MK-677-a-25x25.webp 25w, https://behemothlabz.com/wp-content/uploads/2025/06/MK-677-a-510x510.webp 510w, https://behemothlabz.com/wp-content/uploads/2025/06/MK-677-a-100x100.webp 100w, https://behemothlabz.com/wp-content/uploads/2025/06/MK-677-a-64x64.webp 64w" sizes="auto, (max-width: 344px) 100vw, 344px" /></p>
<p style="margin-bottom: 30px; text-align: center;"><a class="article-blog-btn" href="/product/mk-677-ibutamoren-capsules/"><strong>Buy MK-677</strong></a></p>
<p><span style="font-weight: 400;"><a href="https://behemothlabz.com/product/mk-677-ibutamoren-capsules/">MK-677</a> is also referred to as Ibutamoren. It is an artificial growth hormone secretagogue developed in the laboratory that imitates the growth hormone ghrelin. In preclinical studies, it stimulates the pituitary gland to release growth hormone (GH).</span></p>
<p><span style="font-weight: 400;">This increase in GH also affects the pathways linked to insulin-like growth factor 1 (IGF-1) levels. IGF-1 has been shown to be an important muscle builder, bone modulator, and muscle recovery mechanism as noted in test animals. </span></p>
<p><span style="font-weight: 400;">Researchers use MK-677 orally. Oral MK-677 is more convenient for ongoing lab tests than injections </span><b>(Cardaci et al., 2022).</b></p>
<p><span style="font-weight: 400;">MK-677 shows promise in preclinical studies for increasing lean body mass and reversing protein degradation during calorie restriction in animal models. This brings out its anabolic effects in a controlled experimental environment.</span></p>
<h2><b>What is Testosterone?</b></h2>
<p><span style="font-weight: 400;">The major sex hormone in the male body is testosterone. It is synthesized in the testes and in the adrenal glands </span><b>(Nassar and Leslie, 2023)</b><span style="font-weight: 400;">. Its synthetic versions include testosterone enanthate or cypionate, etc. In labs, scientists use them to study their effects on muscle, bone, and libido in preclinical models.</span></p>
<p><span style="font-weight: 400;">It binds directly to androgen receptors in cells. Activation kick-off gene expression, which stimulates the parameters related to protein synthesis, muscle growth, and strength gain during experiments. </span></p>
<p><span style="font-weight: 400;">In research models, testosterone also regulates the distribution of fats, red blood cell formation, and the mood pathways. Lab studies often administer it via injections to mimic therapeutic replacement and observe rapid changes </span><b>(Xie et al., 2025).</b></p>
<h2><b>Mechanism of Action</b></h2>
<p><span style="font-weight: 400;">The ways MK-677 and Testosterone work differ in their pathways during preclinical research.</span></p>
<h3><b>MK-677:</b></h3>
<p><span style="font-weight: 400;"><a href="https://behemothlabz.com/product/mk-677-ibutamoren-capsules/">MK 677</a> attaches itself to ghrelin receptors (GHSR) in the brain of animal models and activates pulsatile GH production by the pituitary gland, and increases the level of IGF-1. This stimulates the parameters involved in muscle enlargement, fat metabolism, and bone development in experimental animals. It maintains GH pulses like those of nature as opposed to direct GH injections.</span></p>
<p><span style="font-weight: 400;">This potentially improves sleep quality and recovery in lab settings. Research demonstrates that IGF-1 increases in response to a dose that favours the maintenance of nitrogen and gain of lean mass </span><b>(Murphy et al., 1998).</b></p>
<h3><b>Testosterone:</b></h3>
<p><span style="font-weight: 400;">Testosterone diffuses into target cells, where it binds to androgen receptors. The binding induces classical gene transcription via androgen response elements (AREs) in the DNA. This enhances protein production, muscle tissue development, and bone mass in research models. Besides, this also converts to DHT or estradiol to facilitate certain functions, such as those of the prostate and bones.</span></p>
<h2><b>MK677 Effects on Testosterone</b></h2>
<p><span style="font-weight: 400;">As per the preclinical studies on rats, there is no direct linkage between MK677 and testosterone secretion. It means MK677 may not directly influence or suppress the secretion of testosterone in preclinical models during experiments. However, early trials reveal that MK677 may indirectly affect the pathways that may influence testosterone secretion. For instance, improved recovery time and sleep quality are some of the effects of MK677 that may indirectly influence testosterone patterns in research models.</span></p>
<h2><b>Key Similarities Between MK677 and Testosterone</b></h2>
<p><span style="font-weight: 400;">The key similarities between MK677 and testosterone are as follows: </span></p>
<p><b>Both Build Muscle:</b><span style="font-weight: 400;"> Both have been shown a potential to affect muscle hypertrophy in animal models. <a href="https://behemothlabz.com/product/mk-677-ibutamoren-capsules/">MK-677</a> does this through the GH/IGF-1 axis and testosterone via androgen signaling for strength and hypertrophy (Rojas-Zambrano et al., 2025).</span></p>
<p><b>Bone Health Benefits:</b><span style="font-weight: 400;"> They increase bone mineral density and such markers as procollagen. MK-677 elevates markers of formation, whereas Testosterone retards microstructural loss </span><b>(Murphy et al., 2001; Xie et al., 2025).</b></p>
<p><b>Anabolic in Catabolic States:</b><span style="font-weight: 400;"> These two reverse nitrogen wasting. MK-677 in the calorie-restricted models, and Testosterone in hypogonadal simulations </span><b>(Rojas-Zambrano et al., 2025).</b></p>
<p><b>Performance Improvements:</b><span style="font-weight: 400;"> Preclinical evidence links increased physical performance, including power output and recovery.</span></p>
<h2><b>Key Differences Between MK677 and Testosterone</b></h2>
<p><span style="font-weight: 400;">Nonetheless, MK-677 and Testosterone differ in structure, targets, and areas of research. MK-677 avoids HPTA shutdown. Testosterone, on the other hand, is sensitive to PCT in cycles.</span></p>
<table>
<tbody>
<tr>
<td><b>Aspect</b></td>
<td><b>MK 677</b></td>
<td><b>Testosterone</b></td>
</tr>
<tr>
<td><b>Chemical Nature</b></td>
<td><span style="font-weight: 400;">Oral secretagogue, non-peptide ghrelin mimetic </span></td>
<td><span style="font-weight: 400;">Steroid hormone, injectable/prescription preparations</span></td>
</tr>
<tr>
<td><b>Primary Target</b></td>
<td><span style="font-weight: 400;">GH/IGF-1 axis via pituitary/ghrelin receptors</span></td>
<td><span style="font-weight: 400;">Androgen receptors inhibit anabolism</span></td>
</tr>
<tr>
<td><b>Hormone Impact</b></td>
<td><span style="font-weight: 400;">Boosts GH/IGF-1. May decreases the total testosterone but does not decrease the free levels.</span></td>
<td><span style="font-weight: 400;">Directly increases the androgen levels, inhibiting natural production.</span></td>
</tr>
<tr>
<td><b>Applications</b></td>
<td><span style="font-weight: 400;">Growth hormone deficiency, frailty, and sleep in aging animal models</span></td>
<td><span style="font-weight: 400;">Hypogonadism, wasting, bone loss, etc.</span></td>
</tr>
</tbody>
</table>
<h2><b>Associated Side Effects</b></h2>
<p><span style="font-weight: 400;">Side effects are observed in preclinical studies.</span></p>
<h3><b>MK-677:</b></h3>
<ul>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Hunger (due to ghrelin mimicry) increases.</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Water retention</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Mild edema</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Fatigue</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Joint pain</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Numbness</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Potential insulin resistance</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">• Some trials have high prolactin or TSH.</span></li>
</ul>
<p><span style="font-weight: 400;">These are generally temporary, and the effects disappear after usage.</span></p>
<h3><b>Testosterone:</b></h3>
<ul>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Acne and oily skin from sebum surge</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Hair loss or prostate enlargement via DHT</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Elevated red blood cells, risking clots</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Mood swings</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Aggression</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Gynecomastia</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Natural testosterone suppression (overall secretion of natural testosterone decreases in old age and increases with age in men and women)</span></li>
</ul>
<p><span style="font-weight: 400;">High doses amplify risks in models.</span></p>
<h2><b>Legal Status</b></h2>
<p><span style="font-weight: 400;">MK-677 is not approved by the FDA and can only be used for laboratory testing, not for human consumption. Testosterone, on the other hand, is a Schedule III controlled, prescription-only medication.</span></p>
<p><span style="font-weight: 400;">MK-677 is available at tested labs such as </span><a href="https://behemothlabz.com/"><span style="font-weight: 400;">BehemothLabz</span></a><span style="font-weight: 400;">, where researchers can obtain it for preclinical research and have it purified by a third party.</span></p>
<h2><b>Final Thought</b></h2>
<p><span style="font-weight: 400;">Testosterone and MK-677 have distinct mechanisms of action for anabolic effects in preclinical models. The differences between them lie in mechanisms and risks, while they agree on muscle and bone gains. Only allowed in the laboratory, they drive state-of-the-art research on physical composition.</span></p>
<h2><b>Frequently Asked Questions (FAQs).</b></h2>
<h3><b>Where should MK-677 be purchased for laboratory experiments?</b></h3>
<p><span style="font-weight: 400;">BehemothLabz</span><span style="font-weight: 400;"> is first in the list of MK 677 capsules and has independent lab-confirmed purity and quality at competitive prices.</span></p>
<h3><b>What is the purpose of using MK-677 in a laboratory study?</b></h3>
<p><span style="font-weight: 400;">MK 677 is used in labs to investigate GH/IGF-1 stimulation, muscle maintenance, and bone markers in models of catabolic or aging conditions.</span></p>
<h3><b>What is the preclinical use of Testosterone?</b></h3>
<p><span style="font-weight: 400;">The use of testosterone in studies involves investigating muscle strength, bone density, and its impact on performance and wasting in models.</span></p>
<h3><b>What is the role of MK-677 in preclinical muscle studies?</b></h3>
<p><span style="font-weight: 400;">It may provoke GH pulses and IGF-1, leading to increased lean mass, nitrogen equilibrium, and recovery without directly acting as an androgen.</span></p>
<h3><b>Is it possible to test MK-677 with Testosterone in the laboratory?</b></h3>
<p><span style="font-weight: 400;">GH and androgen could synergize when combined in models in order to achieve greater anabolism. Just follow research protocols for safety.</span></p>
<h2><b>References</b></h2>
<ol>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">CARDACI, T. D., MACHEK, S. B., WILBURN, D. T., HEILESON, J. L., HARRIS, D. R., CINTINEO, H. P. &amp; WILLOUGHBY, D. S. 2022. LGD‐4033 and MK‐677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report. </span><i><span style="font-weight: 400;">Experimental physiology,</span></i><span style="font-weight: 400;"> 107</span><b>,</b><span style="font-weight: 400;"> 1467-1476.</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">MURPHY, M., PLUNKETT, L., GERTZ, B., HE, W., WITTREICH, J., POLVINO, W. &amp; CLEMMONS, D. 1998. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. </span><i><span style="font-weight: 400;">The Journal of Clinical Endocrinology &amp; Metabolism,</span></i><span style="font-weight: 400;"> 83</span><b>,</b><span style="font-weight: 400;"> 320-325.</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">MURPHY, M., WEISS, S., MCCLUNG, M., SCHNITZER, T., CERCHIO, K., CONNOR, J., KRUPA, D., GERTZ, B. &amp; GROUP, M.-A. S. 2001. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. </span><i><span style="font-weight: 400;">The Journal of Clinical Endocrinology &amp; Metabolism,</span></i><span style="font-weight: 400;"> 86</span><b>,</b><span style="font-weight: 400;"> 1116-1125.</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">NASSAR, G. N. &amp; LESLIE, S. W. 2023. Physiology, testosterone.</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">ROJAS-ZAMBRANO, J. G., ROJAS-ZAMBRANO, A., ROJAS-ZAMBRANO, A. F. &amp; ROJAS-ZAMBRANO SR, A. F. 2025. Impact of testosterone on male health: a systematic review. </span><i><span style="font-weight: 400;">Cureus,</span></i><span style="font-weight: 400;"> 17.</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">XIE, Y., PAN, M., ZHANG, Z., ZHANG, L., LIU, H., WANG, X., LU, W. W., TANG, P. &amp; GE, W. 2025. Testosterone Delays Bone Microstructural Destruction via Osteoblast‐Androgen Receptor‐Mediated Upregulation of Tenascin‐C. </span><i><span style="font-weight: 400;">Advanced Science</span></i><b>,</b><span style="font-weight: 400;"> e01518.</span></li>
</ol>
]]></content:encoded>
					
					<wfw:commentRss>https://behemothlabz.com/mk-677-vs-testosterone-comparison/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Is Ostarine a Steroid?</title>
		<link>https://behemothlabz.com/is-ostarine-a-steroid/</link>
					<comments>https://behemothlabz.com/is-ostarine-a-steroid/#respond</comments>
		
		<dc:creator><![CDATA[Team BehemothLabz]]></dc:creator>
		<pubDate>Wed, 28 Jan 2026 11:46:49 +0000</pubDate>
				<category><![CDATA[SARMs]]></category>
		<category><![CDATA[sarms]]></category>
		<guid isPermaLink="false">https://behemothlabz.com/?p=138562</guid>

					<description><![CDATA[Ostarine sparks debate in research circles. Many wonder whether it counts as a steroid due to its muscle-related reputation or a SARM. To uncover this mystery, this blog explores the true nature of Ostarine. What is Ostarine? Buy Ostarine (MK-2866) Ostarine is a selective androgen receptor modulator (SARM), known as MK-2866 or Enobosarm. In preclinical [...]]]></description>
										<content:encoded><![CDATA[<p><span style="font-weight: 400;">Ostarine sparks debate in research circles. Many wonder whether it counts as a steroid due to its muscle-related reputation or a SARM. To uncover this mystery, this blog explores the true nature of Ostarine.</span></p>
<h2><strong>What is Ostarine?</strong></h2>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-112538" src="/wp-content/uploads/2021/11/B4-Ostarine-MK-2866-20mg-60ct-BH-3-scaled-510x680-1.webp" alt="Ostarine MK2866 Capsules" width="274" height="366" /></p>
<p style="margin-bottom: 30px; text-align: center;"><strong><a class="article-blog-btn" href="/product/ostarine-mk-2866-liquid/">Buy Ostarine (MK-2866)</a></strong></p>
<p><span style="font-weight: 400;">Ostarine is a selective androgen receptor modulator (SARM), known as MK-2866 or Enobosarm. In preclinical models, developers developed SARMs that are specific to certain tissues, including muscle and bone. It was first synthesized in the late 2000s. It is a potential research tool for conditions involving muscle loss. Its chemical structure mimics certain hormone pathways. Nonetheless, it does not work in a similar manner to conventional steroids.</span></p>
<p><span style="font-weight: 400;">It binds selectively to androgen receptors. This selectivity sets it apart from steroids. Studies highlight its development for preclinical exploration only. Purity matters in lab settings.  BehemothLabz supplies high-quality research-grade Ostarine for such purposes in your preclinical research work.</span></p>
<h2><strong>What are Anabolic Steroids? </strong></h2>
<p><span style="font-weight: 400;">Anabolic steroids are synthetic compounds derived from naturally occurring testosterone. They are used for muscle hypertrophy, skeletal health, and adipose tissue reduction. They influence the protein synthetic process once entered the system. Besides, anabolic steroids also cause androgenic effects. </span></p>
<h2><strong>Is Ostarine a Steroid?</strong></h2>
<p><span style="font-weight: 400;">Ostarine is not a traditional anabolic steroid. It is a SARM. It mimics the muscle-building effects of steroids in research models. Here is a detailed overview of why Ostarine is not a steroid. </span></p>
<ul>
<li aria-level="1"><b>Different Origin: </b><span style="font-weight: 400;">Ostarine is laboratory-made, not derived from a hormone. On the other hand, anabolic steroids are derived and developed from hormones, such as testosterone. </span></li>
</ul>
<ul>
<li aria-level="1"><b>Structural Differences: </b><span style="font-weight: 400;">Anabolic steroids contain four carbon rings in their structure. On the other hand, Ostarine lacks this structure and belongs to the SARM class. </span></li>
</ul>
<ul>
<li aria-level="1"><b>Difference in Selective Nature of Binding: </b><span style="font-weight: 400;">Ostarine selectively binds to androgen receptors in muscle and skeletal tissues in preclinical models. On the other hand, anabolic steroids may bind to androgen receptors anywhere. </span></li>
</ul>
<h2><strong>Differences That Show Ostarine Is Not a Steroid</strong></h2>
<table>
<tbody>
<tr>
<td><b>Aspects</b></td>
<td><b>Ostarine (SARM)</b></td>
<td><b>Steroids (Testosterone)</b></td>
</tr>
<tr>
<td><b>Chemical formula</b></td>
<td><span style="font-weight: 400;">C19H14F3N3O3</span></td>
<td><span style="font-weight: 400;">C19H28O2</span></td>
</tr>
<tr>
<td><b>Structure</b></td>
<td><span style="font-weight: 400;">It has a quinolone backbone that enables selective binding.</span></td>
<td><span style="font-weight: 400;">It features a four-ring cyclopentanoperhydrophenanthrene core.</span></td>
</tr>
<tr>
<td><b>Molecular weight</b></td>
<td><span style="font-weight: 400;">389.33 g/mol</span></td>
<td><span style="font-weight: 400;">288.431 g/mol</span></td>
</tr>
<tr>
<td><b>Receptor binding</b></td>
<td><span style="font-weight: 400;">It has a high binding affinity for muscle receptors.</span></td>
<td><span style="font-weight: 400;">Steroids flood androgen receptors, activating gene growth.</span></td>
</tr>
<tr>
<td><b>Selectivity</b></td>
<td><span style="font-weight: 400;">They are highly receptor selective.</span></td>
<td><span style="font-weight: 400;">They are less receptor selective.</span></td>
</tr>
<tr>
<td><b>Metabolism pathways</b></td>
<td><span style="font-weight: 400;">Ostarine undergoes phase I oxidation and then glucuronidation, and its major metabolites include M1 and M2.</span></td>
<td><span style="font-weight: 400;">It favors 17-keto reduction or aromatization.</span></td>
</tr>
</tbody>
</table>
<h2><strong>Benefits or Research Applications of Ostarine</strong></h2>
<p><span style="font-weight: 400;">Ostarine plays a key role in preclinical research. Scientists use it to study muscle and bone responses without broad hormone effects in preclinical models.</span></p>
<h3><b>Muscle Wasting</b></h3>
<p><span style="font-weight: 400;">Scientists experiment on Ostarine in cancer-induced cachexia rats. Cancer cachexia is the condition of muscle loss. The experiment demonstrates the potential for lean development of mass and strength in rat models. Researchers measure fiber size and enzyme activity in leg muscles in preclinical models.</span></p>
<h3><b>Bone Health Studies</b></h3>
<p><span style="font-weight: 400;">Ostarine strengthens bone in preclinical setups. It may build bone density and prevent bone loss in animal models. Fracture-healing tests in orchiectomized rats are compared with testosterone, which supports bone formation in osteoporosis rat models. Rodent assays check balance, gait, and fall prevention via muscle-bone links.</span></p>
<h3><b>Tissue Selectivity Tests</b></h3>
<p><span style="font-weight: 400;">Labs use Ostarine to probe androgen receptor binding in muscle versus prostate cells. It activates genes for growth mainly in targeted areas in research models. Enzyme assays track changes in aerobic capacity in laboratories.</span></p>
<p><span style="font-weight: 400;">Vascularization studies show increased capillarization in the muscles of treated animals. This confirms the compound's non-steroidal properties. Scientists use Ostarine to model selective receptor activation in preclinical muscle cells, bone-healing pathways, or sarcopenia in animals. The preclinical data in rodents investigates the dose-response curve, and scientists compare it to steroids during binding affinity tests.</span></p>
<h2><b>Legality</b></h2>
<p><span style="font-weight: 400;">Ostarine is not approved by the FDA for use outside of research, and its resellers, such as BehemothLabz, market it only for lab use. EU regulations mirror research-only status, patents expired, allowing synthesis for science.</span></p>
<h2><b>Common Misconceptions</b></h2>
<p><span style="font-weight: 400;">Ostarine is mistakenly referred to as a steroid because of its anabolic image. Whereas steroids have a four-ring structure. The selective mechanism is explained by research: "Ostarine is comparable to steroids. Lab evidence shows distinct profiles, and BehemothLabz promotes accurate information for researchers.</span></p>
<p><b>Conclusion</b></p>
<p><span style="font-weight: 400;">Ostarine is a non-steroidal SARM developed for preclinical studies on muscle wasting. Its use in humans as a muscle-building performance enhancer is prohibited by law and in sports. It works by selectively targeting androgen receptors to build lean mass in animal models. Its side effects are less steroid-like; studies are underway to establish its preclinical advantages and side effects in preclinical models.</span></p>
<h2><b>FAQs</b></h2>
<h3><b>What does Ostarine do in preclinical models?</b></h3>
<p><span style="font-weight: 400;">Ostarine (and enobosarm in particular) has the potential to stimulate muscle growth and improve performance in preclinical models.</span></p>
<h3><b>Does Ostarine have an impact on testosterone?</b></h3>
<p><span style="font-weight: 400;">Preclinical studies indicate Ostarine exhibits limited androgenic properties. It means it has less influence on testosterone development and balance in research models.  </span></p>
<h3><b>How long does Ostarine stay in research animals?</b></h3>
<p><span style="font-weight: 400;">The detection windows for Ostarine, LGD-4033, and Andarine range from 3 days to 6 weeks in animal models.</span></p>
<h3><b>Where is Ostarine sold online?</b></h3>
<p><span style="font-weight: 400;">You can buy research-grade Ostarine from BehemothLabz. It provides detailed COAs for each batch and the best-quality SARMS at the most reasonable prices.</span></p>
<h2><b>References</b></h2>
<ol>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Zilbermint, M.F. and Dobs, A.S., 2009. Nonsteroidal selective androgen receptor modulator Ostarine™ in cancer cachexia. </span><i><span style="font-weight: 400;">Future Oncology</span></i><span style="font-weight: 400;">, </span><i><span style="font-weight: 400;">5</span></i><span style="font-weight: 400;">(8), pp.1211-1220.</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Hoffmann, D.B., Komrakova, M., Pflug, S., von Oertzen, M., Saul, D., Weiser, L., Walde, T.A., Wassmann, M., Schilling, A.F., Lehmann, W. and Sehmisch, S., 2019. Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis. </span><i><span style="font-weight: 400;">Journal of bone and mineral metabolism</span></i><span style="font-weight: 400;">, </span><i><span style="font-weight: 400;">37</span></i><span style="font-weight: 400;">(2), pp.243-255.</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Roch, P.J., Henkies, D., Carstens, J.C., Krischek, C., Lehmann, W., Komrakova, M. and Sehmisch, S., 2020. Ostarine and Ligandrol improve muscle tissue in an ovariectomized rat model. </span><i><span style="font-weight: 400;">Frontiers in endocrinology</span></i><span style="font-weight: 400;">, </span><i><span style="font-weight: 400;">11</span></i><span style="font-weight: 400;">, p.556581.</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Komrakova, M., Furtwängler, J., Hoffmann, D.B., Lehmann, W., Schilling, A.F. and Sehmisch, S., 2020. The selective androgen receptor modulator ostarine improves bone healing in ovariectomized rats. </span><i><span style="font-weight: 400;">Calcified tissue international</span></i><span style="font-weight: 400;">, </span><i><span style="font-weight: 400;">106</span></i><span style="font-weight: 400;">(2), pp.147-157.</span></li>
<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Böker, K.O., Komrakova, M., Fahrendorff, L., Spelsberg, B.R., Hoffmann, D.B., Schilling, A.F., Lehmann, W., Taudien, S. and Sehmisch, S., 2023. Treatment of osteoporosis using a selective androgen receptor modulator ostarine in an orchiectomized rat model. </span><i><span style="font-weight: 400;">Endocrine</span></i><span style="font-weight: 400;">, </span><i><span style="font-weight: 400;">81</span></i><span style="font-weight: 400;">(3), pp.579-591.</span></li>
</ol>
]]></content:encoded>
					
					<wfw:commentRss>https://behemothlabz.com/is-ostarine-a-steroid/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>An Overview of SARMS Pills</title>
		<link>https://behemothlabz.com/an-overview-of-sarms-pills/</link>
					<comments>https://behemothlabz.com/an-overview-of-sarms-pills/#respond</comments>
		
		<dc:creator><![CDATA[Team BehemothLabz]]></dc:creator>
		<pubDate>Mon, 26 Jan 2026 13:32:57 +0000</pubDate>
				<category><![CDATA[SARMs]]></category>
		<category><![CDATA[sarms]]></category>
		<guid isPermaLink="false">https://behemothlabz.com/?p=138418</guid>

					<description><![CDATA[Selective Androgen Receptor Modulators (SARMs) come in several forms. They exist in the form of liquids, which are absorbed quickly, injectable for precise dosing, powders that can be mixed according to requirements, and pills. SARMs pills are the most preferred form of SARMs for preclinical research. These pills have pre-measured doses, are easily swallowed, and [...]]]></description>
										<content:encoded><![CDATA[<span style="font-weight: 400;">Selective Androgen Receptor Modulators (SARMs) come in several forms. They exist in the form of liquids, which are absorbed quickly, injectable for precise dosing, powders that can be mixed according to requirements, and pills. SARMs pills are the most preferred form of SARMs for preclinical research. These pills have pre-measured doses, are easily swallowed, and are easily portable, unlike the mess and needles.</span>

<span style="font-weight: 400;">This blog explains in detail what SARMS Pills are, their benefits, and side effects. Read this blog to gain insights into SARMS Pills.</span>
<h2><strong>What are SARMS Pills?</strong></h2>
<span style="font-weight: 400;">SARMs pills are oral formulations of Selective Androgen Receptor Modulators. They are known for their potential tissue-selective interactions, primarily influencing pathways related to muscle hypertrophy and skeletal health [1].</span>
<h3><strong>Structural Foundations</strong></h3>
<span style="font-weight: 400;">Unlike steroidal androgens, SARMs exhibit reduced affinity for receptors in prostate or skin tissues of preclinical models. Enobosarm (GTX-024 or MK-2866) and ligandrol (LGD-4033) are prototypical examples, with binding affinities measured in cell lines using competitive assays [2]. </span>

<span style="font-weight: 400;">Their pharmacokinetic complexity is due to quinolone derivatives (a structural change), such as RAD140. The half-life of oral preparations is found to be between 16 and 24 hours preclinically. This supports once-daily dosing in rodent models [3].</span>
<h2><strong>Mechanism of Action</strong></h2>
<span style="font-weight: 400;">SARMs translocate to the nucleus following receptor binding. They recruit coactivators to androgen response elements on DNA. This selective agonism enhances protein synthesis in muscle cells of preclinical models. In return, these proteins are utilized to influence repair, regeneration, and growth patterns of muscle tissue in preclinical models. </span>
<h2><strong>Common Research Variants of SARMs</strong></h2>
<span style="font-weight: 400;">Common research variants of SARMS include:</span>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Ostarine (MK2866)</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Ligandrol (LGD-4033)</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">RAD140 (Testolone)</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Andarine (S4)</span></li>
</ul>
<span style="font-weight: 400;">Stacks in multi-compound protocols, such as RAD140 with MK-677 analogs, are also available at BehemtohLabz for experiments. </span>
<h2><strong>Research Applications/Potential Benefits of SARMs Pills</strong></h2>
<span style="font-weight: 400;">SARMs modulate muscle remodeling, stabilize fat, and increase energy expenditure in animal models. This potentially aids in sarcopenia without prostate impacts. Other research applications include:</span>
<h3><strong>Impacts Muscle Hypertrophy</strong></h3>
<span style="font-weight: 400;">Muscle hypertrophy has been observed in preclinical models as a result of various physiological changes during laboratory experiments. Some SARMs, like LGD-4033, modulate myostatin inhibition (a protein that limits muscle growth). By inhibiting the pathways regulated by myostatin, these SARMs could affect muscle mass and growth in preclinical models.</span>

<span style="font-weight: 400;">Some SARMs influence protein synthesis in preclinical models. In return, proteins affect the repair and regeneration of damaged muscle tissues in preclinical models. This could lead to lean muscle mass in research models. [2]</span>
<h3><strong>Research Applications of SARMs Pills in Skeletal Health</strong></h3>
<span style="font-weight: 400;">In ovariectomized rat models, SARMs increase trabecular bone volume and cortical thickness by stimulating osteoblast cell activity [1]. Ligandrol enhances mineralization in osteoblast cells in research subjects. It offers sustained effects post-treatment in postmenopausal simulations [2]. </span>

<span style="font-weight: 400;">Andarine may reduce bone resorption markers in fracture-healing studies, thereby accelerating callus formation [6]. Combined muscle-bone effects appear in aged mice. Ostarine boosts both appendicular lean mass and femoral strength in mice [5].</span>
<h3><strong>Affect Adipose Tissue Reduction (Fat Metabolism)</strong></h3>
<span style="font-weight: 400;">SARMs pills may also affect the process of fat metabolism in preclinical models. Some early studies suggest increased lipolysis during experiments. In research models, SARMs pills have been shown to break down large fatty acid molecules into shorter ones through lipolysis. By doing so, scientists observed an overall reduction in adipose tissue in preclinical models. </span>
<h3><strong>Research Applications In Oncology-Related Studies</strong></h3>
<span style="font-weight: 400;">SARMs may mitigate muscle loss post-immobilization [1]. SARMs may inhibit androgen-responsive breast cancer xenografts via AR antagonism in preclinical models during the experiment[4].</span>
<h2><strong>Safety Assessment of SARMs</strong></h2>
<span style="font-weight: 400;">Safety assessments report reversible HDL reductions and mild ALT elevations at supratherapeutic doses.  It usually resolves upon cessation. A systematic review found adverse events comparable to placebo, primarily lab perturbations like suppressed total testosterone. Cardiovascular metrics, including hemoglobin rises &lt;3%, appeared dose-proportional without thrombotic signals in monitored settings [2]. SARMs are tools for cachexia and frailty, though unapproved with safety caveats.</span>
<h2><strong>Which One Is Best: Liquid, Injectables, or Pills? </strong></h2>
<span style="font-weight: 400;">Liquids are preferred for research accuracy, quick uptake, and custom mg doses. However, cons may include bitter alcohol taste and travel restrictions.​ Injectable forms are uncommon and may carry a higher contamination risk. Pills or capsules are convenient, stable, and easier to swallow, hence can be considered the best. </span>
<h2><strong>Side Effects of SARMs</strong></h2>
<span style="font-weight: 400;">SARMs exhibit several disadvantages and side effects in preclinical models. It is primarily due to their interactions with the androgen receptor. These dangers explain why their position remains investigational.</span>

<span style="font-weight: 400;">The general adverse effects of SARMs are:</span>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Hepatic Toxicity</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Hormonal Suppression</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Cardiovascular and Other Risk</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Nausea</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Headaches</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Fatigues</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">Musculoskeletal Concerns</span></li>
</ul>
<b><i>Note: These side effects were observed during preclinical studies on SARMs pills. Further investigation may delve deeper into the compounds. </i></b>
<h2>Legal Status</h2>
<span style="font-weight: 400;">The FDA considers SARMs pills to be unapproved new drugs, and their market use is prohibited. They have not yet received any approval, but scientists/researchers must find suppliers that comply with regulations and industrial standards, such as BehemothLabz, which guarantees COAs to IRB protocols.</span>
<h2><b>Final Thoughts</b></h2>
<span style="font-weight: 400;">SARMs pills are promising research utilities in the study of tissue-selective effects of anabolic agents. It shows lean muscle mass and bone density accrued during preclinical trials. The SARMs pills are progressing in the field of endocrine studies, but they require caution because of poor profiles and regulatory barriers. No human consumption endorsements exist.</span>
<h2><strong>Frequently Asked Questions (FAQs)</strong></h2>
<h3><strong>How do SARMs work?</strong></h3>
<span style="font-weight: 400;">SARMs bind only to androgen receptors in muscle and bone tissues, thereby influencing protein synthesis, osteoblast cell activity, and lipolysis in preclinical models.</span>
<h3><strong>What are the SARMs pills in laboratory research?</strong></h3>
<span style="font-weight: 400;">SARMs are also being studied in laboratory settings to investigate their effects on patterns associated with muscle hypertrophy and skeletal health in preclinical models. </span>
<h3><strong>Are SARMs associated with liver damage in preclinical models?</strong></h3>
<span style="font-weight: 400;">There are some preliminary studies suggesting that SARMs may have an impact on liver function, but further studies are underway to substantiate this claim.</span>
<h3><strong>Which side effects of SARMs pills can be identified?</strong></h3>
<span style="font-weight: 400;">They may be nauseogenic, fatigenic, hepatic, toxic, and hormone-inhibitory.</span>
<h2><b>References</b></h2>
<ol>
 	<li><span style="font-weight: 400;"> Bond, P., et al., </span><i><span style="font-weight: 400;">Selective androgen receptor modulators: a critical appraisal.</span></i><span style="font-weight: 400;"> Frontiers in Endocrinology, 2025. </span><b>16</b><span style="font-weight: 400;">: p. 1634799.</span></li>
 	<li><span style="font-weight: 400;"> Vignali, J.D., et al., </span><i><span style="font-weight: 400;">Systematic review of safety of selective androgen receptor modulators in healthy adults: implications for recreational users.</span></i><span style="font-weight: 400;"> Journal of Xenobiotics, 2023. </span><b>13</b><span style="font-weight: 400;">(2): p. 218-236.</span></li>
 	<li><span style="font-weight: 400;"> Lesnak, J.B., et al., </span><i><span style="font-weight: 400;">Selective androgen receptor modulator microparticle formulation reverses muscle hyperalgesia in a mouse model of widespread muscle pain.</span></i><span style="font-weight: 400;"> Pain, 2023. </span><b>164</b><span style="font-weight: 400;">(7): p. 1512-1523.</span></li>
 	<li><span style="font-weight: 400;"> Borecki, R., P. Byczkiewicz, and J. Słowikowska-Hilczer, </span><i><span style="font-weight: 400;">Selective androgen receptor modulators (SARMs)—potential anabolic drugs for the treatment of cachexia and frailty syndrome.</span></i><span style="font-weight: 400;"> Endokrynologia Polska, 2025.</span></li>
 	<li><span style="font-weight: 400;"> Bhasin, S. and R. Jasuja, </span><i><span style="font-weight: 400;">Selective androgen receptor modulators as function-promoting therapies.</span></i><span style="font-weight: 400;"> Current Opinion in Clinical Nutrition &amp; Metabolic Care, 2009. </span><b>12</b><span style="font-weight: 400;">(3): p. 232-240.</span></li>
 	<li><span style="font-weight: 400;"> Holderbaum, A., </span><i><span style="font-weight: 400;">Emerging anabolic drugs: investigation of the in vitro and in vivo metabolism of selective androgen receptor modulators</span></i><span style="font-weight: 400;">. 2020, Queen's University Belfast.</span></li>
</ol>]]></content:encoded>
					
					<wfw:commentRss>https://behemothlabz.com/an-overview-of-sarms-pills/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>S23 SARM:  Scientific Guide</title>
		<link>https://behemothlabz.com/s23-sarm-guide/</link>
					<comments>https://behemothlabz.com/s23-sarm-guide/#respond</comments>
		
		<dc:creator><![CDATA[Team BehemothLabz]]></dc:creator>
		<pubDate>Wed, 07 Jan 2026 11:16:18 +0000</pubDate>
				<category><![CDATA[SARMs]]></category>
		<category><![CDATA[sarms]]></category>
		<guid isPermaLink="false">https://behemothlabz.com/?p=137252</guid>

					<description><![CDATA[S23 SARM is a pioneer in preclinical studies in androgen research. It provides unprecedented tissue selectivity, which motivates the development of models for muscle hypertrophy, bone density, and fat metabolism. Realize the potential of its research using BehemothLabz. Get to the bottom of the S23 mechanisms, applications, and side effects to make musculoskeletal discoveries at [...]]]></description>
										<content:encoded><![CDATA[<span style="font-weight: 400;">S23 SARM is a pioneer in preclinical studies in androgen research. It provides unprecedented tissue selectivity, which motivates the development of models for muscle hypertrophy, bone density, and fat metabolism. Realize the potential of its research using BehemothLabz.</span>

<span style="font-weight: 400;">Get to the bottom of the S23 mechanisms, applications, and side effects to make musculoskeletal discoveries at the next level.</span>
<h2><strong>What is S23 SARM?</strong></h2>
<span style="font-weight: 400;">S23 is a non-steroidal SARM of the aryl propionamide class. Its initial synthesis occurred in the early 2000s to study endocrine and musculoskeletal. Its high affinity for androgen receptors (AR) is valuable to researchers because it enables tissue-selective action in preclinical models. It is possible to state that S23 has a significant anabolic effect in skeletal muscle and bone, unlike the case of traditional anabolic-androgenic steroids (AAS).</span>

<span style="font-weight: 400;">The initial research identified S23 as a potential aid in androgen therapy modeling. BehemothLabz provides S23 with HPLC purity over 99 percent, supported by third-party certificates of analysis (CoAs) for batches traceable to the lot. These characteristics allow reproducible doses in cell-based and rodent experiments.</span>
<h2><strong>Mechanism of Action</strong></h2>
<span style="font-weight: 400;">S23 SARM binds well with androgen receptors (AR) as a complete agonist to replicate the effects of testosterone selectively in muscle and bone and with minimal effects on the prostate. It may enter the cells, bind to AR with high affinity, and stimulate the receptor. It may influence gene expression to affect muscles (anabolic) and inhibit LH/FSH through negative feedback, thereby preventing contraceptive effects (Jones et al., 2009).</span>
<h2><strong>Properties Of S23 SARM</strong></h2>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><b>Molecular Formula:</b><span style="font-weight: 400;"> C₁₈H₁₃ClF₄N₂O₃</span></li>
 	<li style="font-weight: 400;" aria-level="1"><b>Molecular Weight:</b><span style="font-weight: 400;"> 416.76 g/mol</span></li>
 	<li style="font-weight: 400;" aria-level="1"><b>PubChem ID:</b><span style="font-weight: 400;"> 168269</span></li>
</ul>
<h2><strong>Key Research Applications</strong></h2>
<span style="font-weight: 400;">Preclinical models employ S23 to probe muscle hypertrophy. Here, it may induce dose-dependent increases in fiber cross-sectional area in the soleus and extensor digitorum longus muscles of orchidectomized rats. </span>

<span style="font-weight: 400;">Bone research may reveal enhanced mineral density and trabecular architecture via micro-CT, mimicking androgen replacement without prostate hyperplasia (Wen et al., 2025).</span>

<span style="font-weight: 400;">Fat metabolism studies demonstrate S23’s role in lipolysis pathways. It may reduce epididymal fat pad mass in high-fat diet simulations through AR-mediated HSL activation. Male contraception models highlight reversible spermatogenesis suppression. </span>

<span style="font-weight: 400;">It may reduce sperm counts while preserving proxies of libido, such as mounting behavior (Christiansen et al., 2020). S23 may be integrated into combinatorial assays with peptides such as TB-500 for wound healing or IGF-1 analogs for myogenesis (Ameline et al., 2022).</span>
<h2><strong>Potential Benefits in Studies</strong></h2>
<span style="font-weight: 400;">The potential benefits of S23 SARM in studies are as follows: </span>
<h3><strong>Muscle Growth</strong></h3>
<span style="font-weight: 400;">S23 enhances lean body mass and body weight in castrated rats, as well as supporting protein synthesis and hypertrophy. The animal models exhibit harder, denser muscles that are better retained by the user during the process of making cuts.</span>
<h3><strong>Fat Reduction</strong></h3>
<span style="font-weight: 400;">It lowers the mass dose-dependently of fat in rats, and increases lipolysis (the breakdown of large fatty acid molecules into smaller ones).  Besides, it may also cause body compositional changes without reducing muscle mass in preclinical models. </span>
<h3><strong>Bone Strength</strong></h3>
<span style="font-weight: 400;">S23 may influence mineral transportation and density of the bones in preclinical models. These things facilitate bone density, skeletal health, and injury prevention of bones in research models during experiments.</span>
<h2><strong>Safety and Considerations</strong></h2>
<span style="font-weight: 400;">Preclinical tolerability is dose-dependent and reversible. Regulatory status deems S23 unapproved by the FDA for non-research applications, with WADA listing it as a prohibited anabolic agent. Risks associated with the lab include contamination in the event of non-sterile reconstitution. </span>

<span style="font-weight: 400;">Long-term models detect lipid changes (HDL decrease), and LFT rises (which can be reversed with cessation), which is why these changes should be monitored during multi-dose regimens (Dahleh et al., 2025).</span>
<h2><strong>Associated Side Effects</strong></h2>
<span style="font-weight: 400;">S23 SARM studies in lab animals show side effects that change based on dose, which help researchers understand risks:</span>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">It may cause hormonal changes in animal models.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">It may shift blood fat and sugar in animal models.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">It may affect organs in animal models.</span></li>
</ul>
<h2><strong>Legal Status</strong></h2>
<span style="font-weight: 400;">S23 SARM is not allowed for human consumption as the FDA has not yet approved it. However, researchers can use it in laboratory experiments with preclinical models.</span>

<span style="font-weight: 400;">Expert support encompasses reconstitution and stacking protocols, complements peptides such as Survodutide, and facilitates privacy-focused transactions (crypto/credit) for institutional procurement.</span>
<h2><strong>Conclusion</strong></h2>
<span style="font-weight: 400;">S23 advances preclinical AR research with unmatched selectivity, equipping labs for precise musculoskeletal investigations. BehemothLabz elevates experimental rigor through verified quality.</span>
<h2><strong>Frequently Asked Questions (FAQs)</strong></h2>
<h3><strong>What is S23 SARM?</strong></h3>
<span style="font-weight: 400;">S23 is an aryl propionamide-based non-steroidal SARM, which was manufactured in the early 2000s to conduct endocrine and musculoskeletal studies. It exhibits an affinity to tissue-selective action through high androgen receptor in preclinical models.</span>
<h3><strong>What are some of the most important applications of S23?</strong></h3>
<span style="font-weight: 400;">Muscle hypertrophy, bone density using micro-CT, fat lipolysis in high-fat model animals, and reversible spermatogenesis inhibition in contraception have been used preclinically.</span>
<h3><strong>What are the safety issues involved with S23 experiments?</strong></h3>
<span style="font-weight: 400;">The effects are dose-dependent and reversible; not FDA-approved for non-laboratory use; WADA-banned. It is also essential to monitor lipids and LFTs in the long-term models to prevent the risk of contamination.</span>
<h3><strong>Which side effects does S23 SARM have in models?</strong></h3>
<span style="font-weight: 400;">Dose-dependent in animals: hormone drops (testosterone), changes in blood fats (HDL down), small sugar increases, and organ changes (prostate gland growth or heart thickening).</span>
<h3><strong>Why is BehemothLabz the best choice to use in S23?</strong></h3>
<span style="font-weight: 400;">Claims more than 99 percent purity in CoA, discrete delivery, DOA money back, and specialist steps instructions to co-purify with peptides such as Survodutide.</span>
<h2><strong>References</strong></h2>
<ol>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Ameline, A., Gheddar, L., Raul, J.-S., &amp; Kintz, P. (2022). In vitro characterization of S-23 metabolites produced by human liver microsomes, and subsequent application to urine after a controlled oral administration. </span><i><span style="font-weight: 400;">Journal of pharmaceutical and biomedical analysis, 212</span></i><span style="font-weight: 400;">, 114660.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Christiansen, A. R., Lipshultz, L. I., Hotaling, J. M., &amp; Pastuszak, A. W. (2020). Selective androgen receptor modulators: the future of androgen therapy? </span><i><span style="font-weight: 400;">Translational andrology and urology, 9</span></i><span style="font-weight: 400;">(Suppl 2), S135.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Dahleh, M. M. M., Boeira, S. P., Segat, H. J., Guerra, G. P., &amp; Prigol, M. (2025). A SARM a Day Keeps the Weakness Away: A Computational Approach for Selective Androgen Receptor Modulators (SARMs) and Their Interactions with Androgen Receptor and 5-Alpha Reductase Proteins. </span><i><span style="font-weight: 400;">ACS omega, 10</span></i><span style="font-weight: 400;">(29), 31649-31667.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Jones, A., Chen, J., Hwang, D. J., Miller, D. D., &amp; Dalton, J. T. (2009). Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception. </span><i><span style="font-weight: 400;">Endocrinology, 150</span></i><span style="font-weight: 400;">(1), 385-395.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Wen, J., Syed, B., Leapart, J., Shehabat, M., Ansari, U., Akhtar, M., Razick, D., &amp; Pai, D. (2025). Selective androgen receptor modulators (SARMs) effects on physical performance: a systematic review of randomized controlled trials. </span><i><span style="font-weight: 400;">Clinical endocrinology, 102</span></i><span style="font-weight: 400;">(1), 3-27.</span></li>
</ol>]]></content:encoded>
					
					<wfw:commentRss>https://behemothlabz.com/s23-sarm-guide/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Are SARMs Legal In the USA?</title>
		<link>https://behemothlabz.com/are-sarms-legal-in-the-usa/</link>
					<comments>https://behemothlabz.com/are-sarms-legal-in-the-usa/#respond</comments>
		
		<dc:creator><![CDATA[Team BehemothLabz]]></dc:creator>
		<pubDate>Mon, 05 Jan 2026 11:22:38 +0000</pubDate>
				<category><![CDATA[SARMs]]></category>
		<category><![CDATA[sarms]]></category>
		<guid isPermaLink="false">https://behemothlabz.com/?p=137128</guid>

					<description><![CDATA[Are SARMS legal in the USA? The question every researcher wants to understand before embarking on a research journey. To answer this question, it is concluded that SARMs have not yet approved by the Food and Drug Administration (FDA) for human use. Only scientists and researchers can use them for investigations. But the question is, [...]]]></description>
										<content:encoded><![CDATA[<span style="font-weight: 400;">Are SARMS legal in the USA? The question every researcher wants to understand before embarking on a research journey. To answer this question, it is concluded that SARMs have not yet approved by the Food and Drug Administration (FDA) for human use. Only scientists and researchers can use them for investigations.</span>

<span style="font-weight: 400;">But the question is, “Why have SARMS not been approved for human consumption? What are the factors behind it? What could be the future possibility of SARMs’ regulatory status? Find the answers to all these questions in this blog!</span>
<h2><strong>Understanding SARMs</strong></h2>
<span style="font-weight: 400;">SARMs stand for Selective Androgen Receptor Modulators. They are designed to replace traditional steroids and demonstrate anabolic effects in preclinical models. The working mechanism of SARMs differs from that of conventional anabolic steroids. They bind to selective androgen receptors in muscle and bone tissues in preclinical models.</span>

<span style="font-weight: 400;">This selective binding restricts their influence to the targeted muscles. In preclinical settings, SARMs have modulated pathways involved in muscle hypertrophy, skeletal health, and fat metabolism in research models.</span>
<h2><strong>Are SARMs Legal in the USA?</strong></h2>
<span style="font-weight: 400;">Regarding the legal status of SARMs, they are currently listed as prohibited by the Food and Drug Administration (FDA) of the USA. The FDA does not allow the use of these compounds for human consumption. However, these compounds are widely used in laboratory research on non-human research models to explore their effects.</span>

<span style="font-weight: 400;">If they are prohibited, then why are the selling ratios of these compounds so high? There is one reason behind this: a laboratory experiment. It means SARMs are widely used by many scientists and researchers to understand and investigate how these compounds work. But their use must be in a closed environment by using non-human models.</span>
<h2><strong>Why Are SARMs Illegal In the USA?</strong></h2>
<span style="font-weight: 400;">There are multiple reasons behind the illegality of SARMs for human use. Let’s discuss a few of them below:</span><b></b>
<ul>
 	<li aria-level="1"><b>FDA’s Safety Concerns:</b></li>
</ul>
<span style="font-weight: 400;">The FDA has shown concerns regarding the safety issues of SARMs. Their concerns arose due to limited research investigations on these compounds. Due to this, it has enlisted all SARMs in the prohibited list of items for human consumption.</span>
<ul>
 	<li aria-level="1"><b>Potential Risks:</b></li>
</ul>
<span style="font-weight: 400;">Various potential risks, including hormonal disturbances, liver toxicity, and androgenic effects, are associated with SARMs’ use. Given these potential risks, the use of SARMs is not permitted for human consumption. The FDA has enlisted them in the prohibited list of items. </span>
<ul>
 	<li aria-level="1"><b>Limited Research Findings: </b></li>
</ul>
<span style="font-weight: 400;">Not much is known about SARMs except for their potential in preclinical trials. Therefore, the officials of the FDA worry about their safety concerns for human use. Based on these limited research trials, the FDA has labelled them as prohibited for human consumption. </span>
<ul>
 	<li aria-level="1"><b>To Prevent Misuse: </b></li>
</ul>
<span style="font-weight: 400;">Various online sellers are selling SARMs for bodybuilding and improving athletic performance, which is illegal. To prevent this misuse of all SARM compounds, the Food and Drug Administration has declared them illegal. </span>
<h2><strong>Legal Status of SARMs in Sports </strong></h2>
<span style="font-weight: 400;">Regarding the legal status of SARMs in sports, they are not allowed for human consumption asl well. The World Anti-Doping Agency (WADA) strictly prohibits athletes from using any kind of supplements. Using these supplements can help them improve their athletic performance. Therefore, the WADA strictly prohibits the use of any supplement, including SARMs, by sportsmen or athletes, </span>
<h2><strong>Future Legality Status of SARMs</strong></h2>
<span style="font-weight: 400;">The future always depends on the present. The present decides what the future will be. In the case of SARMs, they are deliberately studied in laboratories to assess their potential benefits. Some early studies have also suggested their potential to influence multiple pathways in preclinical models.  </span>

<span style="font-weight: 400;">If these experiments on preclinical models prove beneficial, the FDA and other regulatory authorities would approve their use for humans. However, in the current scenario, they are only allowed for laboratory use using non-human models. </span>
<h2><strong>Final Thought </strong></h2>
<span style="font-weight: 400;">SARMs are currently illegal for human consumption because of the safety concerns and potential risks they carry. Moreover, their use for sports activities is also prohibited. Their future use for humans depends on the ongoing research in the laboratory. </span>
<h2><strong>Frequently Asked Questions (FAQs)</strong></h2>
<h3><strong>Do SARMs show up on drug tests? </strong></h3>
<span style="font-weight: 400;">Yes, SARMs may show up on drug tests. The traces of SARMs can be detected by taking blood or urine sample from users. </span>
<h3><strong>Do SARMs damage the liver of research models? </strong></h3>
<span style="font-weight: 400;">Some early studies suggest that SARMs may affect the parameters involved in the effective liver functions of preclinical models. </span>
<h3><strong>Do SARMs affect testicle size? </strong></h3>
<span style="font-weight: 400;">No, SARMs have no impact on the testicle size. They only affect muscle hypertrophy, skeletal health, and fat metabolism in preclinical models. </span>
<h3><strong>Can humans use SARMs?</strong></h3>
<span style="font-weight: 400;">No, humans cannot use SARMs, as they are currently on the prohibited list of the Food and Drug Administration. </span>
<h2><strong>References: </strong></h2>
<ol>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Barrios, M. Mendoza, et al. "SARMs, Metabolic Modulators and Growth Hormone Secretagogues in Suspected Illegal Medicines, Bought as Sport Performance Enhancers: A Retro‐and Prospective Study Within the GEON." Drug Testing and Analysis (2025).</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Hahamyan, Henrik A., and Shehzad Basaria. "Selective Androgen Receptor Modulators—Transformative Drugs or Heralds of the Next Drug Epidemic?" JAMA 331.16 (2024): 1359-1360.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Kintz, Pascal. "The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in a human athlete." Journal of pharmaceutical and biomedical analysis 207 (2022): 114433.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Chakrabarty, Rima, et al. “For research use only”: a comprehensive analysis of SARMs and related IPEDs purchased on local Australian websites between 2017 and 2018." Performance Enhancement &amp; Health 9.3-4 (2021): 100201.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Efimenko, Iakov V., et al. "Analysis of the growing public interest in selective androgen receptor modulators." Andrologia 53.11 (2021): e14238.</span></li>
</ol>]]></content:encoded>
					
					<wfw:commentRss>https://behemothlabz.com/are-sarms-legal-in-the-usa/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>SARMs VS SERMs Comparison</title>
		<link>https://behemothlabz.com/sarms-vs-serms-comparison/</link>
					<comments>https://behemothlabz.com/sarms-vs-serms-comparison/#respond</comments>
		
		<dc:creator><![CDATA[Team BehemothLabz]]></dc:creator>
		<pubDate>Mon, 05 Jan 2026 11:22:34 +0000</pubDate>
				<category><![CDATA[SARMs]]></category>
		<category><![CDATA[sarms]]></category>
		<category><![CDATA[serms]]></category>
		<guid isPermaLink="false">https://behemothlabz.com/?p=137135</guid>

					<description><![CDATA[Despite sounding the same, SARM and SERM are two different research compounds. SARMs stand for Selective Androgen Receptor Modulators, whereas SERM stands for Selective Estrogen Receptor Modulator. SARMs show affinity for androgen receptors, whereas, SERM shows affinity for estrogen receptors.  They also share similarities, key potential benefits, and differences. Let’s understand SARMS, SERMs, their key [...]]]></description>
										<content:encoded><![CDATA[<span style="font-weight: 400;">Despite sounding the same, SARM and SERM are two different research compounds. SARMs stand for Selective Androgen Receptor Modulators, whereas SERM stands for Selective Estrogen Receptor Modulator. SARMs show affinity for androgen receptors, whereas, SERM shows affinity for estrogen receptors. </span>

<span style="font-weight: 400;">They also share similarities, key potential benefits, and differences. Let’s understand SARMS, SERMs, their key potential benefits, and differences in this blog. </span>
<h2><strong>What are SARMs? </strong></h2>
<span style="font-weight: 400;">SARMs stand for Selective Androgen Receptor Modulators. They are currently being investigated as alternatives to the conventional steroids. Unlike traditional steroids, SARMs bind to androgen receptors only in the muscle and bone tissues of preclinical models.</span>

<span style="font-weight: 400;">Following this binding, SARMs influence various pathways related to multiple effects in preclinical models. Some of these pathways are involved in muscle hypertrophy, skeletal health, fat metabolism, and regeneration of tissues in preclinical models. </span>
<h3><strong>Famous SARMs: </strong></h3>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">RAD-140</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">LGD-4033</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">MK2866</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Ostarine</span></li>
</ul>
<h2><strong>What are SERMs?</strong></h2>
<span style="font-weight: 400;">SERMs stand for Selective Estrogen Receptor Modulators. They are currently being investigated in various studies related to hormonal imbalance and fertility issues in preclinical models. SERMs bind with estrogen receptors to demonstrate their impacts. But this binding is also selective.</span>

<span style="font-weight: 400;">Sometimes, this binding may activate the patterns linked to estrogen, while at other times, it may inhibit estrogen secretion in preclinical models. These two-way mechanisms may affect osteoporosis, bone health, and hormonal imbalance in preclinical models. </span>
<h3><strong>Famous SERMs: </strong></h3>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Clomiphene Citrate</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Tamoxifene</span></li>
</ul>
<h2><strong>Research Applications of SARMs and SERMs</strong></h2>
<span style="font-weight: 400;">The research applications observed during preclinical compounds on these compounds are as follows: </span>
<h3><strong>Research Applications of SARMs: </strong></h3>
<span style="font-weight: 400;">All these research applications, mentioned below, have been observed in preclinical models. No human model has been used in any laboratory experiments. </span>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">SARMs affect muscle hypertrophy</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">SARMs affect skeletal health and bone integrity</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">SARMs modulate the patterns of fat metabolism </span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">SARMs influence the repair and regeneration of tissues</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">SARMs impact lean muscle mass</span></li>
</ul>
<h3><strong>Research Applications of SERMs: </strong></h3>
<span style="font-weight: 400;">The following research applications of SERMs have been observed during preclinical trials on non-human models. </span>
<ul>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">SERMs affect the activities of estrogen </span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">They may also inhibit or activate estrogen secretion</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">They also affect osteoporosis</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">SERMs have also affected the hormonal imbalance </span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">They have influenced infertility issues </span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">They have also affected malignant neoplasms</span></li>
</ul>
<b><i>Note: All these research applications have been observed in preclinical trials. Therefore, further research investigations may explore further applications of these compounds. </i></b>
<h2><strong>Key Differences Between SARMs VS SERMs</strong></h2>
<span style="font-weight: 400;">Despite being used in research studies, these compounds differ in many aspects. Some of the key differences between these two compounds are as follows: </span>
<table>
<tbody>
<tr>
<td><b>Differences</b></td>
<td><b>SARMs</b></td>
<td><b>SERMs</b></td>
</tr>
<tr>
<td><b>Different Structure </b></td>
<td><span style="font-weight: 400;">SARMs contain aromatic rings and nitrogen-containing heterocycles. They are designed to mimic the testosterone effects in preclinical models.</span></td>
<td><span style="font-weight: 400;">SERMs stand for Selective Estrogen Receptor Modulators. They contain a benzothiophene structure and a triphenylethylene core. </span></td>
</tr>
<tr>
<td><b>Different Mechanism of Action</b></td>
<td><span style="font-weight: 400;">SARMs bind to androgen receptors in the muscle and bone tissues of preclinical models. This binding modulates anabolic effects in these areas.  </span></td>
<td><span style="font-weight: 400;">SERMs bind to estrogen receptors. This binding modulates either the activation or inhibition of estrogen in preclinical models. </span></td>
</tr>
<tr>
<td><b>Functions and Applications</b></td>
<td><span style="font-weight: 400;">Research applications of SARMs include muscle hypertrophy, bone health, fat metabolism, and regeneration of tissues in preclinical models.</span></td>
<td><span style="font-weight: 400;">Research applications of SERMs include modulating hormonal imbalance, affecting fertility issues, and influencing osteoporosis in preclinical models. </span></td>
</tr>
<tr>
<td><b>Differ in Risks </b></td>
<td><span style="font-weight: 400;">The risks of SARMs include liver toxicity, hormonal suppression, and fatigue in preclinical models. </span></td>
<td><span style="font-weight: 400;">The risks of SERMs include mood changes, hormonal imbalance, and vision issues in preclinical models. </span></td>
</tr>
<tr>
<td><b>Different Legal Status</b></td>
<td><span style="font-weight: 400;">The FDA has not yet approved any SARM for human consumption. They are only allowed for laboratory experiments. </span></td>
<td><span style="font-weight: 400;">SERMs are prescribed chemicals. They can be bought if followed by a verified prescription. </span></td>
</tr>
<tr>
<td><b>Hormonal Effects</b></td>
<td><span style="font-weight: 400;">SARMs affect the pathways related to the hormonal imbalance of testosterone. They may, sometimes, suppress the basal levels of testosterone in preclinical models. </span></td>
<td><span style="font-weight: 400;">SERMs only affect the hormonal balance of estrogen in preclinical models. They may, sometimes, modulate estrogen levels in preclinical models. </span></td>
</tr>
</tbody>
</table>
<h2><strong>Legal Status of SARMs and SERMs</strong></h2>
<span style="font-weight: 400;">Regarding the legal status of SARMs and SERMs, they have not been approved by the Food and Drug Administration for human use. Therefore, selling SARMs and SERMs for human use is strictly prohibited. Only scientists and researchers can use these compounds for laboratory experiments. </span>
<h2><strong>Final Thought </strong></h2>
<span style="font-weight: 400;">SARMs and SERMs are two different research chemicals. They have been investigated in different studies. SARMs are studied for their potential effects on muscle hypertrophy and skeletal health, whereas SERMs are investigated for estrogen-related experiments. These compounds differ in structure, mechanism of action, and research applications from each other. </span>
<h2><strong>Frequently Asked Questions (FAQs)</strong></h2>
<h3><strong>What are SARMs used for in laboratory experiments? </strong></h3>
<span style="font-weight: 400;">SARMs are used in laboratory experiments to investigate their effects on muscle and bone tissues in preclinical models. Scientists are interested in understanding how SARMs affect multiple pathways by binding to androgen receptors in research models. </span>
<h3><strong>Are SARMs toxic to the liver of preclinical models? </strong></h3>
<span style="font-weight: 400;">Some preclinical model studies suggest that SARMs may be toxic to the liver. This assumption was based on the initial trials on the compounds. It needs further investigation to support this claim.  </span>
<h3><strong>What is the purpose of SARMs? </strong></h3>
<span style="font-weight: 400;">The purpose of SARMs is to understand how they interact with androgen receptors in preclinical models. Scientists are curious to know what pathways SARMs modulate in preclinical models. </span>
<h3><strong>What are SERMs? </strong></h3>
<span style="font-weight: 400;">SERMs are Selective Estrogen Receptor Modulators. They modulate the levels of estrogen hormone in preclinical models. </span>
<h3><strong>How do SERMs work? </strong></h3>
<span style="font-weight: 400;">SERMs bind with estrogen receptors in preclinical models. This binding affects the level of estrogen hormones in research models. </span>
<h2><strong>References: </strong></h2>
<ol>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Narayanan, Ramesh, Christopher C. Coss, and James T. Dalton. "Development of selective androgen receptor modulators (SARMs)." Molecular and cellular endocrinology 465 (2018): 134-142.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Gao, Wenqing, and James T. Dalton. "Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)." Drug discovery today 12.5-6 (2007): 241-248.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Negro-Vilar, Andrés. "Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium." The Journal of Clinical Endocrinology &amp; Metabolism 84.10 (1999): 3459-3462.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Komm, Barry S., and Sebastian Mirkin. "An overview of current and emerging SERMs." The Journal of steroid biochemistry and molecular biology 143 (2014): 207-222.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Pickar, James H., Tanya MacNeil, and Kathleen Ohleth. "SERMs: progress and future perspectives." Maturitas 67.2 (2010): 129-138.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Mirkin, Sebastian, and James H. Pickar. "Selective estrogen receptor modulators (SERMs): a review of clinical data." Maturitas 80.1 (2015): 52-57.</span></li>
</ol>]]></content:encoded>
					
					<wfw:commentRss>https://behemothlabz.com/sarms-vs-serms-comparison/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Are SARMs illegal To Possess?</title>
		<link>https://behemothlabz.com/are-sarms-illegal-to-possess/</link>
					<comments>https://behemothlabz.com/are-sarms-illegal-to-possess/#respond</comments>
		
		<dc:creator><![CDATA[Team BehemothLabz]]></dc:creator>
		<pubDate>Mon, 05 Jan 2026 11:22:23 +0000</pubDate>
				<category><![CDATA[SARMs]]></category>
		<category><![CDATA[sarms]]></category>
		<category><![CDATA[serms]]></category>
		<guid isPermaLink="false">https://behemothlabz.com/?p=137131</guid>

					<description><![CDATA[Are SARMs legal to possess? What do the FDA and International law say about it? Are online vendors allowed to sell SARMs for experiments? These are the questions that need to be understood before delving into the world of SARM.  In this blog, we discuss all these questions in detail. Read it and understand the [...]]]></description>
										<content:encoded><![CDATA[<span style="font-weight: 400;">Are SARMs legal to possess? What do the FDA and International law say about it? Are online vendors allowed to sell SARMs for experiments? These are the questions that need to be understood before delving into the world of SARM. </span>

<span style="font-weight: 400;">In this blog, we discuss all these questions in detail. Read it and understand the legal status and response of international laws to SARM. </span>
<h2><strong>Understanding SARMs</strong></h2>
<span style="font-weight: 400;">SARMs are the synthetic alternatives to the traditionally found anabolic steroids. They stand for Selective Androgen Receptor Modulators. The term selective means that SAMs have the potential to bind with androgen receptors in specific areas, not everywhere. </span>

<span style="font-weight: 400;">This selective binding with androgen receptors makes SARMs the best research chemical to be studied further. Some early studies on SARMs have explored their potential in affecting muscle mass, fat metabolism, and skeletal health in preclinical models. Similarly, SARMs have also modulated the pathways linked to the repair and regeneration of tissues in research models during experiments. </span>
<h2><strong>Are SARMs Illegal To Possess? </strong></h2>
<span style="font-weight: 400;">No, SARMs are not illegal to possess; they are only illegal if they are possessed for human consumption. If a researcher possesses them with the intention to study their unexplored nature, then there are no legal proceedings against them. However, the research models used in the investigations must be non-human. </span>

<span style="font-weight: 400;">Currently, SARMs are not in the Schedule III list (prohibited list) or the Controlled list of substances. Despite the FDA’s strong stance against SARMs, a grey area remains for research and investigation. Researchers and scientists benefit from this grey zone and possess SARMs for investigations and experiments. </span>
<h2><strong>Federal Laws Regarding SARMs' Legal Status </strong></h2>
<span style="font-weight: 400;">Currently, SARMs have not been approved by the Food and Drug Administration for human use. This means no one can sell and use them for human consumption. However, they have not been placed in the prohibited list or Schedule III list of the United States. Items like narcotics and other drugs are placed in the Schedule III list.</span>

<span style="font-weight: 400;">Additionally, the Senate also proposed the following laws regarding the legal status of SARMs, but these laws have not been approved.</span><b></b>
<ul>
 	<li aria-level="1"><b>Selective Androgen Receptor Modulators Control Act 2018</b></li>
 	<li aria-level="1"><b>SARMs Control Act of 2019</b></li>
</ul>
<span style="font-weight: 400;">These laws did not become law, as the majority of senators disapproved of them. In short, they are not currently in the Schedule III/Prohibited list of drugs. At the same time, they have also not been approved by the FDA for human consumption. Their status lies in the middle. </span>
<h2><strong>International Laws Regarding SARMs Possession </strong></h2>
<span style="font-weight: 400;">At the international level, there exists a mixed regulatory status. Some countries allow the use of SARMs for human consumption, while others strictly prohibit them. In Australia, possession of SARMs is legal if followed by a prescription from a medical expert. In the United States, the FDA does not approve SARMs for human consumption based on safety concerns.</span>

<span style="font-weight: 400;">In the United Kingdom, possession of SARMs is not illegal, but their human consumption is strictly prohibited. In Canada, the state strictly prohibits the possession and use of SARMs for human consumption. </span>
<h2><strong>FDA’s Stance on SARMs</strong></h2>
<span style="font-weight: 400;">The FDA believes that the experiments regarding SARMs’ benefits used non-human preclinical models. Therefore, we cannot say that they are beneficial for humans as well. So, anyone who possesses SARMs with the intention of selling and using SARMs by humans, legal proceedings may be initiated against them. However, this excludes possession of SARMs for research and investigational purposes.</span>

<span style="font-weight: 400;">In the past, the FDA has already issued warning letters to companies that sold SARMs for human consumption. Moreover, the FDA believes that a company must clarify that its compounds are purely for research and laboratory purposes, not for human use and benefits. </span>
<h2><strong>Final Status </strong></h2>
<span style="font-weight: 400;">It is legal to possess SARMs, but it is illegal to use them for human consumption. The FDA strictly prohibits the use of these chemicals for human consumption. Many attempts have also been proposed to regulate the status of SARMs, but they have not become federal laws. </span>
<h2><strong>Frequently Asked Questions (FAQs)</strong></h2>
<h3><strong>What is the FDA's stance on SARMs’ use? </strong></h3>
<span style="font-weight: 400;">The FDA does not approve the use of SARMs for human consumption. The SARMs have not been approved by the FDA. </span>
<h3><strong>Can SARMs be used for laboratory purposes? </strong></h3>
<span style="font-weight: 400;">Yes, SARMs can be used for laboratory experiments and investigational purposes. But researchers must use non-human research models.  </span>
<h3><strong>Can humans use SARMs? </strong></h3>
<span style="font-weight: 400;">No, humans cannot use SARMs, as the FDA strictly prohibits them due to safety concerns. </span>
<h3><strong>Which law regulates SARMs status? </strong></h3>
<span style="font-weight: 400;">The Food and Drug Administration regulates the status of the stance. The FDA does not allow the use of SARMs for human consumption. There is no federal-level law regarding the regulatory status of SARMs. </span>
<h3><strong>What does the Schedule III list about? </strong></h3>
<span style="font-weight: 400;">Schedule III includes all those items, including narcotics and drugs, that are prohibited for human consumption. </span>
<h2><strong>References: </strong></h2>
<ol>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Barrios, M. Mendoza, et al. "SARMs, Metabolic Modulators and Growth Hormone Secretagogues in Suspected Illegal Medicines, Bought as Sport Performance Enhancers: A Retro‐and Prospective Study Within the GEON." Drug Testing and Analysis (2025).</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Gaudiano, Maria Cristina, et al. "Illegal products containing selective androgen receptor modulators purchased online from Italy: health risks for consumers." Sexual Medicine 12.2 (2024): qfae018.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Kintz, Pascal. "The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in a human athlete." Journal of pharmaceutical and biomedical analysis 207 (2022): 114433.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Chakrabarty, Rima, et al. “For research use only”: a comprehensive analysis of SARMs and related IPEDs purchased on local Australian websites between 2017 and 2018." Performance Enhancement &amp; Health 9.3-4 (2021): 100201.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Vasireddi, Nikhil, et al. "Athlete Selective Androgen Receptor Modulators Abuse: A Systematic Review." The American Journal of Sports Medicine 53.4 (2025): 999-1009.</span></li>
 	<li style="font-weight: 400;" aria-level="1"><span style="font-weight: 400;">Leciejewska, Natalia, et al. "Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: analysis of suspected cases." European Journal of Clinical Pharmacology 80.2 (2024): 185-202.</span></li>
</ol>]]></content:encoded>
					
					<wfw:commentRss>https://behemothlabz.com/are-sarms-illegal-to-possess/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
